Mutations in the adenomatous polyposis coli (APC) gene in patients with familial adenomatous polyposis (FAP) with congenital hypertrophy of the retinal pigment epithelium (CHRPE). by Keung, Wing Ying. & Chinese University of Hong Kong Graduate School. Division of Surgical Sciences.
Mutations in the Adenomatous Polyposis Coli (APC) 
gene in patients with Familial Adenomatous Polyposis 
(FAP) with Congenital Hypertrophy ofthe Retinal 
Pigment Epithelium (CHRPE) 
By 
Keung Wing Ying 
Thesis submitted for the Degree of 
Master of Philosophy 
Division of Surgical Sciences 




| ^ J 6 服腳)gJ 
W T UNIVERSITY~/^J 
v^H'BRARY SYSTEMy^^ 






List of Tables vn 
List of Figures yin 
Chapter 1 Introduction 1 
1.1 Familial Adenomatous Polyposis (FAP) 1 
1.1.1 Occurrence and prevalence 1 
1.1.2 Clinical features 2 
1.1.3 Laboratory studies 5 
1.1.4 Diagnosis 5 、 
1.1.5 Management g 
1.2 Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) g 
1.2.1 Clinical features 9 
1.2.2 Pathogenesis \\ 
1.2.3 Histology 12 
1.2.4 Differential diagnosis 13 
1.2.5 CHRPE as an early clinical marker for FAP 14 
1.3 The Adenomatous Polyposis Coli (APC) Gene 16 
1.3.1 Discovery 16 
1.3.2 Structure and function 17 
1.3.3 Sequence alterations in the APC gene 18 
1.3.4 APC mutations associated with specific clinical features 21 
1.3.5 APC gene mutations in Chinese 22 
1.3.6 Methods for detecting mutation in the APC gene and linkage 
analysis 23 
Chapter 2 Study Objectives 44 
Chapter 3 Methodology 45 
3.1 Subjects 45 
3.2 CHRPE analysis 45 
3.2.1 Ophthalmoscopic examination 45 
3.2.2 Diagnostic criteria of CHRPE 45 
3.3 Materials and Equipment 46 
3.3.1 Enzymes 46 
3.3.2 D N A markers 46 
3.3.3 Reagent kits 46 
3.3.4 Primers for PCR 46 
3.3.5 Chemicals and reagents 47 
3.3.6 Radioisotopes 47 
3.3.7 Solutions and buffers 47 
3.3.8 Equipment 48 
3.4 Methods 49 
3.4.1 Blood collection 49 
3.4.2 D N A extraction 49 
3.4.3 D N A quantitation 50 
3.4.4 Polymerase Chain Reaction (PCR) 50 
3.4.5 Agarose gel electrophoresis 51 
3.4.6 Single Strand Conformation Polymorphism (SSCP) 52 
3.4.7 Direct D N A sequencing 52 
3.4.8 Analysis of microsatellite markers 54 
Chapter 4 Results 59 
4.1 Study subjects 59 
4.1.1 FAP index patients 59 
4.1.2 FAP families 59 
4.1.3 Control subjects with CHRPE only 60 
4.1.4 Normal control subjects 60 
4.2 CHRPE analysis 60 
4.2.1 CHRPE in FAP index patients 60 
4.2.2 CHRPE in family members 61 
4.2.3 CHRPE in controls subjects 61 
4.2.4 Statistical analysis 61 
4.3 PCR optimization 62 
4.4 SSCP analysis of the APC gene 62 
4.5 Direct D N A sequencing analysis 63 
4.5.1 Nonsense mutations 53 
4.5.2 Novel silent mutations 64 
4.5.3 Polymorphisms 65 
4.6 Haplotype analysis 67 
4.7 Family studies 57 
4.7.1 Family A 67 
4.7.2 Family B 68 
4.7.3 Family C 68 
4.7.4 Family D 69 
4.7.5 Family E 70 
4.7.6 Family F 70 
Chapter 5 Discussion 104 
5.1 The predictive value of CHRPE in FAP patients and family members 104 
5.2 The laboratory techniques in this study 105 
5.2.1 PCR optimization 105 
5.2.2 Single Strand Conformation Polymorphism (SSCP) 106 
5.2.3 Direct D N A sequencing i07 
5.3 Novel mutation in the APC gene 108 
5.4 Reported mutations in the APC gene 108 
5.4.1 3183del5 108 
5.4.2 R216XandR283X 109 
5.5 Novel silent mutations and polymorphisms in the APC gene 109 
5.5.1 Novel silent mutations 109 
5.5.2 Polymorphisms 110 
5.6 The relationship between APC gene mutations and CHRPE 111 
5.7 Haplotype analysis 112 
Chapter 6 Conclusion 114 




Familial Adenomatous Polyposis (FAP) is an autosomal dominant disease characterized by large 
numbers of adenomatous polyps in the colon. Ancillary features of FAP include congenital 
hypertrophy of the retinal pigment epithelium (CHRPE), desmoid tumours, osteomas, and 
epidermoid cysts. CHRPE is the most common extracolonic lesion ofFAP and can be identified 
early after birth. It is regarded as a useful clinical marker for FAP. Aberrations in adenomatous 
polyposis coli (APC) gene are casual for FAP. More than 700 APC mutations have been reported 
in Caucasians and Japanese, but only a 5-base pair (AAAGA) deletion in exon 15 has been 
reported in Chinese. The purpose of this study is to identify APC mutations in Chinese FAP 
patients and to assess the presymptomatic diagnostic value ofCHRPE in FAP. 
Methodology 
A total of55 subjects were recruited including 10 FAP index patients, 33 family members from 6 
families, 4 controls with CHRPE only (unassociated with FAP) and 8 healthy controls. Fifty of 
the 55 study subjects were examined by indirect ophthalmoscopy. The criterion for CHRPE was 
the presence of3 or more CHRPE lesions in one or both eyes. D N A was extracted from venous 
blood in all the study subjects for detection of sequence alterations in exons 6-15 ofthe APC 
gene by Polymerase Chain Reaction (PCR), Single Strand Conformation Polymorphism (SSCP) 
and direct D N A sequencing. Haplotype analysis was performed using 5 microsatellite markers 
flanking the APC gene in 4 FAP families. 
II 
Results 
Nine ofthe 10 FAP patients (the remaining one was not examined by ophthalmoscopy because 
he was terminally ill in FAP at the time of our study) had one or two CHRPE lesions (100%) and 
7 had more than 3 lesions in both eyes (77.8%). Fundal examination was performed on 29 ofthe 
33 family members. Eight of the 29 family members had one or two CHRPE lesions (27.6%), 
but only 2 had more than 3 (6.9%) lesions. CHRPE lesions were not detected in any of the 8 
control subjects. The sensitivity and specificity of CHRPE in FAP were 77.8% and 94.6% 
respectively. In the APC gene, a novel single base insertion at codon 1023 (3068insA) leading to 
a stop codon was detected in one FAP patient. Three previously reported mutations were also 
found: a deletion of 5 base pairs (ACAAA) at codon 1061 (3183del5), two truncating single base 
substitutions at codon 216 (R216X) and 283 (R283X), all the patients with these mutations are 
heterozygous. W e also found 3 new silent mutations (1050T/G, 4965A/G and G~>A in intron 10) 
and 4 polymorphisms (1458C/T, 1635AA3, 4479G/A and 5034A/G). No APC mutation was 
found in 3 out ofthe 10 FAP patients. A high risk haplotype based in microsatellite markers 
flanking the APC gene was found in one FAP family. 
Discussion 
The incidence ofCHRPE in FAP in this study was 77.8% which was within the range 66 to 97% 
as reported in Japanese and Caucasians. The sensitivity and specificity of CHRPE in our FAP 
patients, 0.78 and 0.95 respectively, were also similar to other reports. Although the number of 
FAP patients was small, such results were indicative ofthe possible use of CHRPE as a clinical 
marker for FAP as in other populations. The novel mutation 3068insA was found in a 29-year-
old FAP patient who had 15 CHRPE lesions in both eyes. The previously reported 3183del5 
mutation is a hot spot in the APC gene. It was detected in a 36-year-old FAP woman with 18 
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CHRPE lesions in both eyes. The R216X mutation was found in one FAP patient who showed 5 
CHRPE lesions in both eyes. The R283X mutation was detected in 4 FAP patients and 1 non-
FAP member in one family, 3 of these 5 subjects had more than 3 CHRPE lesions. Our study 
indicated that CHRPE lesions perhaps are serious if mutations occur at codon 1023 and 1061， 
and CHRPE lesions are present if mutation occurs before exon 9 of the APC gene. But further 
analysis ofa large number of patients with mutations is required to confirm whether the position 
of the APC gene mutation is correlated with CHRPE. Although a high risk haplotype was 
determined in one FAP family using microsatellite markers flanking the APC gene, but the 
haplotype analysis was still limited due to small family members were studied. 
Conclusions 
The novel and all 3 previously reported APC mutations found in this study segregated with 
CHRPE in FAP patients. The site of an APC mutation influence CHRPE expression, but is not 
the only factor responsible for the presence and number ofretinal lesion in FAP patients. CHRPE 
itself shows sufficient sensitivity and specificity as a clinical marker for FAP. While 
opthalmologic examination is a direct, noninvasive and inexpensive test for FAP screening, 
occurrence of APC mutations in asymptomatic individuals is also indicative of endoscopy to 
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Chapter 1 Introduction 
1.1 Familial Adenomatous Polyposis (FAP) 
Familial Adenomatous Polyposis (FAP) is a dominant inherited disease characterized by the 
development of hundreds to thousands of adenomatous polyps in the colon (Utsunomiya et al. 
1990). The disease is caused by mutations in the tumor suppressor gene APC (Adenomatous 
Polyposis Coli) on chromosome 5q21-22 (Groden et al., 1991; Joslyn et al., 1991; Kinzler et aL, 
1991 andNishisho etal.，1991). 
1'1.1 Occurrence and prevalence 
FAP has been described for more than a century and was first reported by Sklifosovske in 1881. 
Smith found the association of FAP with cancer in 1887. In 1890, Bickersteth discovered its 
genetic origin, and subsequently Cockayne discovered an autosomal dominant mode of 
inheritance in 1927. The account ofFAP is about 1% in all colorectal cancers (Burt et al., 1985). 
Epidemiologic data suggest that the incidence ofFAP range from 1:8,000 to 1:15,000 after birth 
(Bulow et al., 1986; Utsunomiya et al., 1990 and Jarvinen et al., 1992). The estimation of FAP 
frequency is mainly based on indirect calculations from restricted regional samples. The 
proportion of isolated cases ofFAP ranges from 22% to 46% in registry-based studies (Maher et 
al.，1993; Bisgaard et al., 1994). 
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1.1.2 Clinical features 
Colonic manifestations 
Familial adenomatous polyposis (FAP) is a common and highly penetrant genetic disease. It is 
characterized by numerous adenomatous polyps (>100) in the colon and rectum (Murday & 
Slack，1989) (Figure 1-1). In some extreme cases the bowel is carpeted with a myriad ofpolyps. 
The affected individual typically develops multiple polyps in the colon during the second or third 
decade of life. One or more ofthese adenomas will inevitably progress to adenocarcinoma unless 
the affected colon is removed (Bussey et al., 1990). The presenting features are usually those of 
malignancy such as weight loss, inanition, bowel obstruction or bloody diarrhea. About one third 
of the cases have no family history; the isolated cases that present with symptoms tend to be 
diagnosed at a later age, often with moderate to severe dysplasia or even adenocarcinoma 
(Powell et al.，1990). 
Extracolonic manifestations 
Majority of FAP patients has one or more extracolonic features (Krush et al., 1988). Gardner's 
syndrome and FAP both occur in siblings, and have been mapped to the same chromosomal 
location (Bodmer et al., 1987; Nakamura et al., 1988). They may be associated with identical 
pathological mutations in the APC gene O^ishisho et al., 1991)，so the terms are regarded as 
synonymous. There is evidence to suggest that some extracolonic features of the disease 
correlate with the nature of the mutations. Extracolonic features in FAP can be classified into 3 
groups: 
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(1) Adenomatous polyps in the upper gastrointestinal tract 
This extracolonic feature has become a major determinant oflong-term morbidity. Periampullary 
cancer is a well-recognized feature ofFAP (Jones et al., 1977; Hamed et al., 1982). Offerhaus et 
al. (1992) found that there was a greatly increased risk of duodenal adenocarcinoma and 
ampullary adenocarcinoma in FAP patients. No significant increased risk was found for gastric 
or nonduodenal small intestinal cancer. Burt et al. (1984) suggested that the prevalence ofgastric 
cancer in Japan may be associated with the greater frequency of this type of malignancy in 
Japanese carriers of the APC gene defect. 
(2) Ocular, cutaneous, and skeletal features 
Blair et al. (1980) pointed out that congenital hypertrophy ofthe retinal pigment epithelium 
(CHRPE) is an usual feature present in Gardner's syndrome and can be a valuable clue to the 
predisposition of Gardner's syndrome in persons who have not yet developed other 
manifestations. Consequently, CHRPE is recognized as the most common extracolonic 
manifestation ofFAP and an early clinical marker ofthe disease (Diaz-Llopis et al., 1988; Lyons 
et al., 1988). CHRPE would be reviewed in this section later. In Gardner syndrome, polyps ofthe 
colon and sometimes of the stomach and small intestine are associated with osseous and soft 
tissue tumors. Globoid osteomata of the mandible with overlying fibromata are characteristic 
(Ushio et al., 1976; Jagelman et al., 1987). Osteomatous changes in the calvaria with associated 
fibromas (of the forehead, for example) are also noted. Sebaceous or epidermoid cysts occur on 
the back. Dental anomalies in Gardner's syndrome were first described by Fader et al. (1962). 
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Jarvinen et al. (1982) found jaw osteomata in 76% and dental anomalies in 18% of patients. 
These dental anomalies include impacted teeth, supernumerary teeth, congenitally missing teeth, 
and abnormally long and pointed roots on the posterior teeth (Carl et al., 1987). 
0) Tumors and malignancy in organs outside the gastrointestinal tract 
FAP registry studies have shown that occurrence of tumors and malignancy is not limited to the 
gastrointestinal tract of patients with FAP. Some patients are affected with desmoid tumors, 
hepatoblastoma, thyroid carcinoma, mesenteric fibromatosis and other rare forms of cancer or 
neoplasm. The slow growing lesions of desmoid tumors are invasive and can reach enormous 
sizes. Though usually located with the abdominal cavity, they may develop anywhere in the body. 
Some studies have identified desmoid tumors (from 6% to 31%) to be one ofthe most common 
extracolonic causes of mortality (Arvanitis et al.，1990; Bertario et al., 1994; Belchetz et al.， 
1996). Klemmer et al. (1987) found an increase in the frequency of desmoids in persons with 
FAP ofthe colon, but the risk was dependent on age and sex. The lifetime risk was estimated to 
be 8% for males and 13% for females. It affected more elderly than young people. The incidence 
ofhepatoblastoma in FAP patients is 1 in 100,000 (Giardiello et al., 1991). Thyroid carcinoma in 
Gardner's syndrome was first described by Camiel et al. (1968). In 1995，Herve et al. reviewed a 
large number of published references and estimated that the incidence of thyroid carcinoma in 
patients with Gardner's syndrome approached 100 times that ofthe general population. Some 
patients may develop fibromatosis, especially after surgery (Simpson et al., 1964). 
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1.1.3 Laboratory studies 
Histological findings 
FAP is characterized by multiple adenomas, averaging less than 5 m m in diameter; the often 
cited number of 100 varies according to the age of the patient. There is no histologic difference 
between adenomas in FAP and those in the general population. Morson and Bussey (1970) 
identified a progressive sequence of epithelial dysplasia with adenomatous tissue at the margins 
ofintestinal cancers, establishing the adenoma as a cancer precursor. 
Biochemistry findings 
The activity of ornithine decarboxylase may be a usefiil marker for the genotype of familial 
polyposis (Luk et al., 1984). This rate-limiting enzyme in the polyamine biosynthetic pathway is 
essential for intestinal mucosal proliferation. Mucosa from dysplastic polyps showed elevated 
ornithine decarboxylase activity when compared to non-dysplastic polyps. Smith et al. (1993) 
produced monoclonal and polyclonal antibodies to adenomatous polyposis coli to characterize 
the protein in normal and tumor cells. They found that 81% ofcolon tumor cell lines were totally 
devoid ofthe normal, full-length protein, whereas 40 cell lines derived from sporadic tumors of 
other organs had full-length APC. Immunohistochemical analysis of APC in normal colonic 
mucosa demonstrated cytoplasmic staining, with higher intensity staining in the basolateral 
margins ofthe epithelial cells. The staining was markedly increased in the upper portions ofthe 
crypts，suggesting an increased level of expression with maturation. 
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Other findings 
Skin fibroblasts from patients with Gardner's syndrome and familial polyposis coli were reported 
to show increased susceptibility to retrovirus-induced transformation and chromosomal 
aneuploidy (Rasheed et al.，1983). Chen et al. (1989) demonstrated that the in vitro life span of 
cultured skin fibroblasts from individuals with FAP was markedly extended when compared with 
that of normal individuals. Midgley et al. (1997) developed antisera to APC N- and C-terminal 
epitopes, and found that the APC protein was expressed in epithelial and mesenchymal cells in 
many tissues. In the epithelium of bladder, small and large intestine, esophagus, stomach, and 
epidermis, APC expression was restricted to regions where cell replication has ceased and 
terminal differentiation is established. The authors concluded that this distribution is compatible 
with APC function related to signaling at the adherens junction and indicates that APC plays a 
role in cells committed to terminal differentiation. 
1.1.4 Diagnosis 
Endoscopy 
It is very important to examine the affected family members and at-risk adolescents and siblings, 
because the affected individual with hundreds of polyps may remain clinically asymptomatic. 
When clinical symptoms are apparent, about two-thirds of such patients would have already 
developed carcinoma of the colon or rectum (Powell et al., 1990). Consequently, screening 
guidelines have been established for ages 10 to 14 years. Frequent examination ofat risk subjects 
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by sigmoidoscopy beginning in the early teens is recommended to detect early adenomas. 
Flexible sigmoidoscopy remains the standard screening procedure because it is minimally 
invasive, allows for biopsy, and is generally acceptable to adolescents. The use ofbarium enema 
is discouraged because of the propensity to overlook early-stage adenomas of size around 1 to 2-
mm. It is recommended every 2 years until age 35 and every 3 to 5 years thereafter for at-risk 
first-degree relatives who have not undergone predictive testing or who are uninformative 
subsequent to D N A analysis. Because the offspring of a patient with FAP has a 50% chance of 
inheriting the defective gene and puberty is the usual age of onset, an adolescent with less than 
10 adenomas and a confirmed family history ofFAP should be considered as affected. 
Dental Panoramic Radiographs Score (DPRS) 
A weighted scoring system for changes on dental panoramic radiographs called the Dental 
Panoramic Radiographs Score (DPRS) could be used as a diagnostic tool for FAP (Thakker et al., 
1995). The score took into account the nature, extent, and sight ofosseous and dental changes, as 
well as the incidence of the anomaly in the general population. Using the highest threshold, a 
specificity of 100% and sensitivity of approximately 68% were obtained. Ifall positive findings 
were considered as significant, sensitivity was increased to approximately 82%, but the 
specificity was reduced to approximately 88%. Overall, approximately 68% of the affected 
subjects had significant changes, and approximately 18% had normal appearance on DPR, with 
the remainder having changes classified as minimal or equivocal. 
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1.1.4 Management 
Waddell and Loughry (1983) were the first to make a connection between nonsteroidal anti-
inflammatory dmgs ^s[SAIDs) and colon cancer. They observed the disappearance of rectal 
polyps in a patient with Gardner's syndrome and correctly attributed this disappearance to 
treatment with sulindac, an NSAID that was given for unrelated reasons. Giardiello et al. (1993) 
found that sulindac, at a dose of 150 mg orally twice a day for 9 months, reduced the number and 
size of colorectal adenomas. The effect has been confirmed in numerous clinical trials (Marcus et 
al., 1995) and the interpretation that NSAIDs promote regression of colon polyps by inhibiting 
prostaglandin synthesis has been supported by genetic studies in mice (Oshima et al., 1996). 
However, up to now, prophylactic colectomy is the preferred and possibly the only effective 
management for those who have developed polyps and are positive gene carriers. 
1.2 Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) 
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) was first discribed by 
Reese and Jones in 1956 in a subject free of other diseases. CHRPE is a benign fundus lesion and 
is usually discovered during routine ophthalmoscopy. But Blair and Trempe (1980) pointed out 
that CHRPE is a frequent finding in Gardner syndrome and can be a valuable clue to the 
presence of the gene in persons who have not yet developed other manifestations. 
9 
1.2.1 Clinical features 
Ophthalmoscopic features 
CHRPE independent ofFAP 
A typical fundus lesion of CHRPE shows a unilateral, solitary, round, flat, circumscribed and 
hyperpigmented lesion. It is well demarcated from normal-appearing retinal pigment epithelium 
(RPE) and is not known to be associated with other ocular or systemic disorders. It may show 
chorioretinal atrophy at the center of the lesion encircled by a narrow halo of hypopigmented 
RPE. The color of the lesion can range from light grayish-brown to black, independent of the 
race ofthe person (Kurz et al., 1962). Punched-out hypopigmented or depigmented lacunae may 
be present within larger lesions. Clinically, the overlying retina and its vasculature appears 
normal in the majority of cases. Some cases showed a longitudinal strip of whitish change 
following the course of an artery, appeared to enclose the blood vessel like a sheath, or a 
longitudinally orientated area of hypo- and hyperpigmentation close to the retinal veins, or 
hyperpigmentation of the RPE under retinal vessels (Schmidt et al., 1994). Occasionally, there 
may be capillary and large-vessel obliteration and neovascularization (Cleary et al., 1976). The 
lesion varies in size from less than 100pm to several disk diameters and can be found anywhere 
in the fundus. While growth of CHRPE is seldomly observed (Norris et al., 1976)，depigmented 
lacunae frequently enlarge or new lacunae may develop within the lesion (Buettner et al., 1975). 
M e n several lesions of varying sizes are arranged in a cluster, resembling the footprint of an 
^imal，they are also referred to as grouped pigmentations or "bear tracks". Figure 1-2 shows a 
picture of CHRPE which is not associated with FAP. 
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CHRPEinFAP 
Lewis et al. (1984) described multiple and bilateral patches ofCHRPE in affected members of3 
families with Gardner's syndrome. The lesions of CHRPE in FAP are multiple, bilateral and 
smaller than lesions unassociated with FAP; some are as small as 50 to 100 ^ m in diameter 
(Figure 1-3). The larger lesions may be surrounded by a depigmented halo, contain depigmented 
lacunae, or may be accompanied by small satellite lesions. The appearance of CHRPE lesions is 
classified into 5 types (Berk et al., 1988)，but the oval pigmented lesion with a pale halo is 
unique to FAP (Polkinghome et al.，1990). The type, size and location of CHRPE in FAP are 
summarized in Table 1-1. Small pigmented black dots in the periphery ofthe retina, the most 
common lesion in FAP, also occur in normal subjects, but in these normal subjects more than 
three lesions are rarely found. Table 1-2 lists the differences between CHRPE in FAP and 
CHRPE unassociated with FAP. 
Vision and visual field 
CHRPE in FAP is asymptomatic and the benign pigmented fundus lesion is the same as that of 
non-FAP. Vision and visual field examination usually is normal, and patients generally do not 
complain of any symptoms related to the lesion, except when the lesion involves the macula. 
E>etailed examination finds the lesions to be associated with corresponding scotomas in the 
visual field. These scotomas tend to be relative in younger patients, but appear absolute in older 
patients. The depth of the scotoma increases with the age of the patient, but these lesions do not 
grow in size (Buettner et al., 1975). 
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Fluorescein angiographic features 
The RPE and choroid adjacent to the area of CHRPE show a normal fluorescein angiographic 
pattern (Buettner et al., 1975). The hypertrophic RPE blocks background choroidal fluorescence, 
augmenting the bright contrast of the retinal vasculature. Through depigmented lacunae or 
hypopigmented halo, a normal choriocapillaris flush is observed. Although leakage of 
fluorescein dye from retinal vessels overlying CHRPE has been reported (Cleary et al., 1976)，in 
the majority oflesions no leakage of dye is observed during any phase of the angiogram. 
Electrophysiologic findings 
The electro-oculogram (EOG) and the electroretinogram (ERG) show normal patterns in eyes 
with CHRPE (Santos et al., 1994). 
1.2.2 Pathogenesis 
CHRPEinFAP 
It was suggested that CHRPE may be associated with APC gene mutations (Olschwang et al., 
1993b; Wallis et al., 1994; Kartheuser et al., 1995; Caspari et al., 1995; Davies et al., 1995). 
Th^e mutations lead to the synthesis of a truncated protein. The extension ofCHRPE was found 
to be dependent on the length of the truncated protein, and the position of mutation along the 
eoded sequence. Exon 9 of the APC gene is a critical boundary for the presence or near absence 
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ofCHRPE. Retinal lesions are almost always absent if the mutation occurs before exon 9, but are 
consistently present if the mutation occurs after this exon. 
CHRPE independent ofFAP 
Observation of CHRPE in newbom infants and young children provides evidence for the 
congenital nature of this lesion (Champion et al” 1989). Relative scotomas with mild 
photoreceptor degeneration in young patients compared to deep, absolute scotomas with 
advanced photoreceptor degeneration in old patients suggest that the abnormality is limited to the 
RPE. Presumably, the abnormal RPE can not maintain the integrity of the photoreceptor cells 
nearby，resulting in not only progressive degeneration totally but also RPE cell death and 
formation of depigmented lacunae. Ultraviolet fluorescence microscopy showed no 
autofluorescent granules of lipofuscin in the CHRPE, suggesting that the lesion's constituent 
cells lack the capacity for phagocytosis and digestion of photoreceptor outer segments (Lloyd et 
al. 1990). Other studies classified CHRPE lesions as hamartomas ofthe RPE (Kasner et al. 1992)， 
or as melanotic nevus (Roseman et al. 1992). 
1.2.3 Histology 
Histopathology reveals a single layer of hypertrophic cells, containing numerous large pigment 
granules, resting on a markedly thickened and strongly positive acid-Schiff (PAS)-positive 
Bruch，s membrane (Buettner et al., 1975; Lloyd et al., 1990). Hyperplastic changes in the form 
ofmultiple layers ofhypertrophic RPE cells have also been reported (Wirz et al., 1982; Kasner et 
al.�1992). The choriocapillaris and the remainder of the choroid are normal underneath the 
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CHRPE lesion. The transition from normal to hypertrophied RPE occurs abruptly. Overlying the 
hypertrophied RPE, the retinal photoreceptor cell layer is markedly degenerated with only a few 
remaining inner and outer segments within amorphous, PAS-positive material. In younger 
patients the photoreceptor cells overlying CHRPE exhibit less advanced degeneration than in 
older people. The inner retinal layers, including the retinal vasculature, are normal. The 
hypopigmented halo, found to surround some lesions of CHRPE, consists of slightly less 
pigmented hypertrophied RPE cell. In the area of the depigmented lacunae, both the hypertrophic 
RPE and photoreceptor cell layer are absent and have been replaced by a multicellular layer of 
glial cells interposed between Bruch's membrane and the normal inner retinal layers (Buettner et 
al.，1975). Under electron microscopy, the thickened Bruch's membrane consists of marked 
widening of the basement membrane of the hypertrophic RPE cells. Surrounding the CHRPE 
lesion，the retina and pigment epithelium is normal. In the area ofhypertrophy, the RPE cells are 
markedly thickened and densely packed with large round pigment granules instead of the 
wedgeshaped melanin granules found in normal RPE cells (Champion et al” 1989). The 
photoreceptor outer segments are missing overlying the abnormal RPE cells. 
1.2.4 Differential diagnosis 
In the vast majority of cases, pigmented ftmdus lesions are easily recognized when using the 
indirect ophthalmoscope and scleral indentation. However, in order to avoid missing out very 
small and lightly pigmented lesions, a three-mirror contact lens examination is necessary when 
no lesions are detected with indirect ophthalmoscopy. Because small numbers of CHRPE may 
occur in normal subjects, the threshold for diagnosing CHRPE positive in FAP are three or more 
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lesions in one or both eyes (Lewis et al., 1984; Romania et al., 1989). CHRPE can easily be 
identified correctly by modem examination techniques. However, descriptions of this lesion in 
earlier reports, along with reviews of older histopathologic data, suggest that CHRPE have been 
frequently misdiagnosed. Most often it has been mistaken for malignant melanoma of the 
choroid, choroidal melanomas, choroidal nevi, melanocytomas, hyperplasia of the RPE or focal 
pigmentation. Choroidal melanomas are almost always elevated, less uniformly pigmented or 
less well demarcated as CHRPE, and exhibit growth. Choroidal nevi are located deep to the RPE 
and are flat. Their color may vary from light to dark brown. The borders are less well demarcated 
than those of CHRPEs and are often feathery because nevus cells extend along larger choroidal 
ves^ls. Melanocytomas of the choroid have a similar appearance, except for their black color. 
True hyperplasia ofthe RPE also has ill-defined borders and invades the retina, often resulting in 
distortion ofthe retina. Focal pigmentation caused by injury, inflammation or drug toxicity may 
resemble CHRPE, but can be differentiated by its more irregular shape, widespread distribution, 
and associated clues suggesting its acquired nature. 
1.2.5 CHRPE as an early clinical marker for FAP 
Traboulsi (1987) reported that the specificity and sensitivity ofbilateral multiple retinal lesions 
as a marker for FAP with extracolonic manifestation were 0.95 and 0.78 respectiviely. Diaz-
Llopis et al. (1988) suggested that CHRPE may be a useful marker to detect patients at risk for 
FAP in families who carry the mutated gene. The combination of features obtained from eye 
examination for CHRPE, information on the age of onset and linked D N A markers appeared to 
be highly effective in carrier detection. Lyons et al. (1988) concluded that the CHRPE phenotype 
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is a more powerful marker than other phenotypic features of Gardner's syndrome. Ophthalmic 
examination was performed on 56 patients with ‘validated，FAP, and 8 patients were found to 
have the retinal lesions without any of the extracolonic features of Gardner's syndrome. It is 
possible that the eye lesion may be the only extracolonic feature of Gardner's syndrome (Baker 
et al., 1988). Houlston et al. (1992) suggested that CHRPE is not an exclusive manifestation of 
mutation at the APC locus. Patients expressing CHRPE tend to cluster within specific polyposis 
families. The proportion of cases of FAP that manifest significant numbers of CHRPE varies 
from 66 to 92% in recent studies (66% by Baker et al., 1988 and Romania et al., 1989; 80% by 
Polkinghome et al., 1990; 87.5% by Berk et al., 1988; 92% by Bum et al., 1991). The 
explanation for these variations is not clear, but it is possible that different ophthalmologists may 
vary in their criteria in recording retinal abnormalities, especially for small lesions. The patient 
populations may also differ. In Chinese, the incidence of CHRPE in FAP patients was 100% in a 
small study involving 7 FAP families and 11 index patients (Lam et al., 1998). A subject at risk 
of inheriting the gene for FAP and whose retinae contained three lesions was estimated to have a 
probability of 67% as a carrier, while the presence of more than three lesions was diagnostic 
(Bum et al., 1991). Since the colonic and extracolonic manifestations of FAP do not develop 
until the second or third decade of life, the discovery of CHRPE at an early age in a person at 
risk for FAP is a valuable aid for genetic counseling and prognostic management. Colectomy at 
the time when polyps develop, long before the progression to adenocarcinoma, is the lifesaving 
treatment of choice. However, the absence of CHRPE lesions in a person at risk does not indicate 
ti^ absence of the gene, since variable ocular expressions of this marker gene exist as with all 
dominantly inherited traits. The detection of multiple, bilateral CHRPE in members of families 
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with inherited intestinal polyposis allows the ophthalmologist to make an important contribution 
to the early recognition of persons at risk for the development ofintestinal malignancies. 
1.3 The Adenomatous Polyposis Coli (APC) Gene 
1.3.1 Discovery 
The chromosomal location of the gene responsible for FAP has been unclear for a long time， 
because no specific deletion has been detected in chromosomes of either the normal or tumor 
tissues from FAP patients. In 1986，Herrea et al. first detected a constitutional interstitial deletion 
of5q in lymphoid cells from a patient with Gardner's syndrome. In 1987, the disease gene was 
mapped to chromosome 5q21-22 by linkage analysis using restriction fragment length 
polymorphisms (RFLPs) (Bodmer et al. and Leppert et al.). Loss of heterozygosity (LOH) on 
chromosome 5q was detected in sporadic colorectal carcinomas in 1987 (Solomon et al.), and 
later in FAP carcinomas by Okamoto et al. in 1988 using RFLP probe Cllpll. Other RFLP 
Probes，including YN5.48, LS5.34, and L5.71 have since been isolated (Meera et al., 1988; 
Nakamura et al., 1988; Dunlop et al., 1990) and confirmed to be closer to the disease gene by 
Hnkage analysis in FAP families. L O H on chromosome 5 suggested that the disease gene is the 
mutant of a tumor suppressor gene. In 1991，isolation ofthe APC gene was achieved by four 
groups (Groden et al., Joslyn et al., Kinzler et al. and Nishisho et al.) using RFLP probes close to 
the APC gene as markers. Consequently, it became possible to clarify the molecular mechanisms 
oftumor formation in FAP patients. 
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1.3.2 Structure and function 
The APC gene is located on chromosome 5q21-22 and consists of 15 exons and 14 introns 
spanning more than 100 kilobases (Kinzler et al., 1991) and encoding 2843 amino acids (Figure 
1-4). Exons 1-14 vary in size from 78 (exon 12) to 379 bp (exon 9)，accounting for 23% ofthe 
protein coding regions of the gene. Exon 15，however, is remarkable for its size, comprising 77% 
of the protein coding sequence. It is one of the largest eukaryotic exons ever described. The 
predicted APC protein is hydrophilic, and it has no potential signal peptides corresponding to 
transmembranal regions, or nuclear targeting signals, suggesting a cytoplasmic localization of 
the protein. The peptide structure has local sequences homologous to myosin and keratin. In the 
NH2-terminal and the central portion, the gene contains sequences that have coiled-coil potential, 
which indicates that the APC protein has the ability to form homo- and hetero-oligomers. 
The function of APC remains unclear but its cellular localization and interactions with other 
protein led to several hypothesis. Rubinfeld et al. and Su et al. (1993a) found that the APC 
protein is associated with adherensjunction protein alpha- and beta-catenin. These proteins bind 
to the cell surface molecule, E-cadherin, and are essential in cellular adhesion. The APC protein 
may affect the interaction between catenins and E-cadherin, thus influencing cellular adhesion 
and possibly intercellular communications. Antibodies to the APC protein have identified a 300-
kE)a cytoplasmic protein expressed in epithelial cells in the upper portions ofthe colonic crypts, 
suggesting that it is functional in the mature colonocytes (Smith et al., 1993). Subcellular 
localization has demonstrated that wild-type APC is closely associated with microtubule 
formation. However, mutant APC proteins do not bind to microtubules (Munemitsu et al., 1994; 
Smith et al., 1994). In vitro studies indicate that wild-type APC not only binds to microtubules 
but also promotes their formation (Munemitsu et al., 1994). Since the organization and structure 
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of microtubules are vital to cell division, it is possible that the association of APC with the 
catenins, and hence cadherin, may afford a direct line of intracellular communication between 
the cell surface and the site of microtubule formation. Mutant APC protein has been shown to 
interact with normal APC, forming a heterodimer which may result in defective function in a 
dominant-negative manner (Su et al., 1993b). The extent to which normal APC function is 
impaired may be related to the structure and residual ability of the mutant protein to form dimers. 
Truncated APC protein due to mutations occurring in the most 5' part of the gene may not be 
capable of dimerization with wild-type APC whereas the more 3' mutations may allow 
translation ofrepeat sequences which can allow dimer formation. Thus, it might be predicted that 
a more aggressive phenotype may result from the more 3' mutations. 
1.3.3 Sequence alterations in the APC gene 
Since the coding sequence of the APC gene has been identified, examination of its mutations 
became possible. The coding sequence includes 8972 nucleotides and the search for mutations is 
rather laborious, but analysis of mutations of the APC gene is important for direct 
Presymptomatic diagnosis of patients not only in FAP families, but also in those without family 
history. Up to now, over 700 both germline and somatic mutations have been reported 
(Christophe et al., 1996). More than 98% of the mutations are frameshift or nonsense mutations 
leading to the synthesis of a truncated protein. This feature clearly indicates that each of these 
mutations is truly deleterious for APC function. Common mutations of the APC gene are 
summaried in Table 1-3. 
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Germ-line mutations of theAPC gene in FAP patients 
Mor than 300 germline mutations of the APC gene have been reported in unrelated FAP patients 
(Christophe et al., 1996). Miyoshi et al. (1992a) detected 53 germ-line mutations in the APC 
gene in 79 unrelated FAP patients using ribonuclease protection analysis coupled with PCR 
amplification of genomic DNA. More than 90% of these mutations appeared to result in 
truncation of the APC protein. Nearly 70% of the mutations were clustered in the 5' halfofexon 
15，and nearly 20% of the total mutations occurred at 5 positions: codons 1309, 1061, 1546，625 
and 302. Germline mutations scattered throughout the 5' half of the gene, but two hot spot 
codons have been identified, one at codon 1061 including the A A A A C 5-base-pair or A A A C 4-
base-pair deletion and the other at codon 1309 including the A A A A G 5-base-pair deletion 
(Miyoshi et al., 1992a; Cottrell et al., 1992; Groden et al., 1993; Varesco et al; 1993, Miyaki et 
al.�1994). It is well known that deletions and insertions in the APC gene often occur at positions 
containing repeated sequences within the coding sequence, and all caused frameshifts, which 
resulted in stop codons downstream. One of the possible causes of such deletions and insertions 
is replication misalignment, which is liable to occur within homopolymeric sequences (Kunkel et 
al., 1990). For example, a 5-base (AAAGA) deletion from A T A A A A G A A A A G A T T at codon 
1309 and a 5-base (ACAAA) deletion from A T A A A A C A A A G T at codon 1061 have been 
detected. It should also be noted that the APC protein truncated at these positions may be 
significant to the inactivation of the APC gene and the cause of the clinical phenotype in FAP 
patients. Other deletions or insertions also occurred in the region within or near the repeated 
sequence. Another characteristic of APC germline mutations is that more than 80% ofthe known 
b^e substitutions are from cytosine to other nucleotides. Such a high frequency of mutation at C 
^ y also be explained by the hypothesis that a large number of mutations from C and G occur as 
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a result oftransient misalignment of the bases at the replication fork (Cooper et al.，1990). It may 
also be due to the fact that FAP is usually caused by inactivation of the APC gene by formation 
of stop codons TGA, T A G and TAA. 
Somatic mutations of theAPCgene in colorectal tumors front FAP and non-FAP patients 
Extensive screening for somatic mutations of the APC gene has been carried out in colorectal 
tumors. More than 400 APC somatic mutations of the APC gene have been described 
(Christophe et al., 1996). A Japanese group screened 138 colorectal adenomas and carcinomas 
including 87 from FAP patients, and found 65 somatic mutations (Miki et al., 1992; Miyoshi et 
al., 1992b; Ichii et al., 1992，1993). Powell et al. performed direct D N A sequencing ofthe entire 
coding region of this gene and detected 35 somatic mutations in 41 colorectal tumors (1992). 
Miyoshi et al. (1992b) reported that over 60% of the somatic mutations in the APC gene were 
clustered within a small region of exon 15, called the mutation cluster region (MCR). 
Approximately 94% of the FAP somatic mutations were clustered between codon 1280 and 1500. 
In contrast, only 29% of germ-line mutations occurred in this region. In 1995, Michiko et al. 
reported several hot spots of somatic mutations in the APC gene including codons 1307-1311, 
1378，1450，1462-1465 and 1478-1490. Two ofthem, at codons 1307-1311 and 1462-1465, are 
hot spots in both germ-line and somatic mutations, but the other three positions were mutated 
only somatically at high frequency. Over 80% of colorectal tumors had at least one mutation in 
the APC gene (Miyoshi et al., 1992b). More than 60% of these had two genetic changes, 
Mutation plus mutation, or mutation plus LOH. They concluded that two genetic alterations of 
the APC gene were necessary for tumor formation. Powell et al. (1992) also examined mutations 
ofthe APC gene in 41 non-FAP colorectal tumors. About 60% of colon cancer had at least one 
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mutation in the APC gene and 64% of these mutations had two genetic changes. It was suggested 
that two genetic changes in the APC gene give a great growth advantage, but may not be 
required for tumorigenesis to occur. Powell et al. also concluded that somatic mutations of the 
APC gene are associated with development of colorectal tumors, not only in FAP patients, but 
also in non-FAP sporadic cases. 
Polymorphisms of theAPC gene 
More than 25 polymorphisms have been identified in the APC gene (Groden et al., 1991;Nagase 
et al., 1992a; Miyoshi et al., 1992; Powell et al., 1992; Nagase et al., 1993; Olschwang et al., 
1993a) and they are summarized in Table 1-4. The allelic frequencies ofthe 5 most common 
polymorphisms were 0.43/0.57 (with or without a cutting site) at codon 486, 0.35/0.65 at codon 
545，0.35/0.65 at codon 1493, 0.64/0.36 at codon 1678 and 0.63/0.37 at codon 1960. Base 
substitution at codons 545 and 1960 do not affect the recognition site ofany restriction enzyme 
but can be easily distinguished by the allele-specific PCR method (Prezan et al., 1992). Allelic 
frequencies among the other 20 polymorphisms were less than 0.05. This information should be 
usefUl for presymptomatic diagnosis ofFAP as well as for studies to examine tumors for the loss 
ofheterozygosity at the APC locus (Yusuke Nakamura 1994). 
1-3.4 APC Mutations Associated with Specific Clinical Features 
Some interesting features were observed by the analysis of APC mutations regarding the possible 
relationship between the localization of the mutation and specific phenotypes associated with the 
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disease. The specific phenotypes include profuse (more than 5000 adenomatous polyps in the 
colon) and sparse (the number of polyps is between 1000 and 2000) types in the number of 
colorectal polyps (Utsunomiya et al., 1990) and differences in the frequency of extracolonic 
manifestations (Jagelman et al., 1987). The correlation between the location ofthe mutation and 
the number of polyps in FAP patients has been noted by Nagase et al. (1992b). In the profuse 
type of FAP patients, the mutations (frameshift mainly) are concentrated between codon 1255 
and 1467. In the sparse type of FAP patients, APC mutations (missense and frameshift) are 
located near the 5' end (codon 97-157) ofthe APC gene (Spirio et al., 1992). It seems that the 
presence ofgermline mutations in the extreme 5' ofthe APC coding regionbefore codon 157 are 
correlated with an attenuated phenotype which has fewer polyps and delayed onset ofthe cancer 
(Spirio et al., 1993). Olschwang et al. (1993a) reported that the severity of Congenital 
Hypertrophy of the Retinal Pigment Epithelium (CHRPE) also depends on the position of the 
mutation. Retinal lesions are almost always absent if the mutation occurs before exon 9, but are 
consistently present if the mutation occurs after this exon. Exon 9 is a transitional exon, with 
CHRPE lesions being present if a mutation occurs in the 3' half of the exon, and absent i fthe 
mutation occurs in the 5' half of the exon. Further analysis of a large number of patients is 
required to determine whether a particular mutation is correlated with a specific phenotype. 
1.3.5 Mutations of the APC gene in Chinese 
There is only one report in the literature regarding mutations ofthe APC gene in FAP patients in 
the Chinese (Gan et al., 1994). Fifty-three FAP patients were from 7 families in HangZhou 
located in the southeastern region of China. Restriction Fragment Length Polymorphism (RFLP) 
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was performed using a specific restriction endonuclease to screen the hot spot mutation at codon 
1309 of the APC gene in these 53 FAP patients. A deletion of 5-base pairs (AAAGA) at codon 
1309-1311 was detected in 10 of 53 FAP patients. The results also agree with the examinations 
by endoscopy. They concluded that mutation patterns of the APC gene in Chinese FAP patients 
might be similar to those of Caucasians. 
1.3.6 Methods for detecting mutations in the APC gene 
There are many different techniques to detect mutations of the APC gene. Table 1-5 summarizes 
the advantages and disadvantages of the methods widely used in different laboratories. 
Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) is used to make large a number of copies of a specific D N A 
sequence. A preparation of D N A is denatured. The single stranded preparation is annealed with 
two short oligonucleotide primer sequences that are complementary to sites on the opposite 
strands on either side of the target region. D N A polymerase is used to synthesize a single strand 
from the 3'-OH end of each primer. The entire cycle can then be repeated by denaturing the 
preparation and starting again (Mullis et al., 1986). For detecting the mutations ofthe APC gene 
in FAP patients, PCR is the basis for preparation of a target D N A fragment for the detection of 
base changes with different methods. 
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Single Strand Conformation Polymorhism (SSCP) 
Single strand conformation polymorphism (SSCP) analysis is a simple method for detecting most 
sequence variations in a single strand of DNA. The conformation of a single strand D N A under 
nondenaturing conditions is uniquel depending upon its sequence composition. This 
conformation is usually different even if a single base has been changed. The difference in 
conformation can be detected as mobility shifts in non-denaturing gel electrophoresis (Orita et al., 
1988). SSCP is performed by denaturing PCR products into single stranded form, cooling rapidly 
to allow single strand self-folding, separating in a non-denaturing acrylamide gel under constant 
electrophoretic conditions and detected by autoradiography or silver staining. The sensitivity of 
SSCP for detecting point mutations can be improved by optimizing the variables involved or 
using a variety of SSCP conditions. Factors that affect SSCP migration and detection include the 
length of the PCR fragment, the temperature of the gel during electrophoresis, the method of 
PCR denaturation, and the characteristics of the gel. The optimal length of a single strand is 
typically between 100-300 nucleotides (Hayashi et al., 1991). Lengthy PCR products may be 
restricted with endonucleases. SSCP is applied widely to screen for APC gene mutations in FAP 
patients and their family members (Miyoshi et al., 1992, Cottrell et al., 1992; Groden et al., 1993; 
Olschwang et al., 1993). 
J>enaturing Gradient GelElectrophoresis (DGGE) 
DGGE is based on the principle that different D N A duplexes will show differences in migration 
as they are forced to migrate through an electrophoretic gel in which there is a gradient of 
increasing amounts of a denaturant, usually a chemical denaturant. Temperature gradient gel 
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electrophoresis is also sometimes used (Cariello et al., 1993). The D N A duplexes continue to 
migrate until they reach a position in the gel where the strands melt and separate, after which the 
denatured D N A does not migrate much further. A single base pair difference between a normal 
and a mutant D N A duplex is sufficient to cause them to migrate differently. D G G E is potentially 
highly sensitive and avoids radioisotopes. However, primers must be designed very carefully 
because the sequence amplified needs the right profile of melting domains. D G G E has been used 
to identify mutations of the APC gene (Riccardo et al., 1992). 
Chemical Cleavage Mismatch (CCM) 
The method is based on the detection of chemical reactions to cleave one strand of the D N A at 
the site of the mismatch. The test sample is mixed with labeled wild-type sequence, denatured 
and allowed to renature. If the test sequence differs from the wild type, heteroduplexes are 
formed which can be cleaved by chemical or enzymic treatment. Cleavage is revealed by 
observing short labeled fragments in a gel. C C M is one of the most sensitive methods of 
mutation detection. It can be applied to kilobase-length samples. The disadvantages are that the 
chemicals are very toxic and some practice is required before it works well. C C M was also 
applied to detect mutations of the APC gene (Smith-Ravin et al., 1994). 
fJeteroduplex Analysis (HAD) 
Heteroduplexes form when PCR products from a heterozygous person are denatured then cooled 
to allow single mutant strands to base pair with complementary strands from the wild-type allele. 
Heteroduplexes in polyacrylamide gels can be detected as extra slow moving bands. Mutations 
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including insertions, deletions and most single base substitutions are detectable if the fragments 
under investigation are less than 200 base pairs (Keen et al., 1991). H A D is mostly used in 
combination with single-strand conformation analysis on a single gel. H A D was applied widely 
in screening the APC gene for mutations (Johanna et al., 1995; Dagan et al., 1996). 
Restriction Fragment Length Polymorphisms (RFLP) 
RFLPs are simply variations in the lengths of the D N A fragments produced by cleaving D N A 
molecules with specific restriction endonucleases. These RFLPs can be visualized directly when 
the fragments in D N A digests are separated by agarose gel electrophoresis, stained with ethidium 
bromide, and viewed under ultraviolet illumination. Individual RFLPs can be detected by using 
specific cDNA or genomic clones as radioactive hybridization probes on genomic Southern blots. 
Mutations alter a restriction site or are comprised of significantly large insertions or deletions 
will create the restriction enzyme cutting site and hence can be detected using this method. RFLP 
was used to detect known mutations of the APC gene in FAP and colorectal cancers O^ ishisho et 
al., 1991). 
Restriction EnzymeAnalysis 
The method is used to detect mutations that create or destroy the cutting site of a restriction 
enzyme. PCR products can be digested with the appropriate restriction enzyme, followed by gel 
electrophoresis. This method can only be applied to detect known mutations, and not all base 
substitutions cause a change at restriction enzyme cutting sites, so the method has limited use for 
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detecting all mutations. Some known mutations and polymorphisms of the APC gene have been 
identified using this method (Gloria et al., 1993; Shozo et al., 1994; Delhanty et al., 1995). 
DirectDNA Sequencing 
The method can detect all known and unknown mutations. Dideoxy chain termination is the most 
widely used approach (Sanger et aL, 1997). This method relies on the ability of 
dideoxynucleotides, which lack the 3' hydroxyl group critical to phosphoribosyl chain extension, 
to terminate a strand synthesis from a specific oligonucleotide priming site by a D N A 
polymerase. The template must be single-stranded DNA. Using suitable mixtures of dideoxy A 
(or C, G or T)，and a deoxynucleotide mix, a range of sequence-specific size fragments is 
generated which can be resolved by electrophoresis to determine the sequence ofthe synthesized 
strand. Chain terminations for a given size fragment should only occur in one gel track (A, C，G, 
or T) in accord and with the specific base pairing of the dideoxynucleotides with the template 
single-strand. The major drawback is the need to use radioisotopes in a laborious procedure. 
Automated sequencing instruments will overcome the disadvantage now. 
Protein Truncation Test (PTT) 
PTT is a rapid, simple and sensitive method for detection of APC gene mutations (Powell et al., 
1993; Van et al., 1994). It can be used to scan large regions of genetic materials by detecting 
translation termination mutations at the protein level. PTT can be used to screen a number of 
exons simultaneously, allowing screening of exons 1-14 of the APC gene injust one or two tests. 
^ A is first isolated from peripheral blood mononuclear cells, APC transcripts are converted to 
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complementary D N A and amplified by reverse transcriptase PCR. The cDNA is amplified with 
PCR using a special forward primer (that includes a T7 promoter, a eukaryotic translation 
initiator with an A T G start codon, and a gene-specific 3' sequence designed so that the sequence 
amplified reads in-frame from the ATG). A coupled transcription-translation system is used to 
produce polypeptide from the amplified coding sequence, which is then checked for size by gel 
electrophoresis. A truncated polypeptide gives rise to smaller-sized products, the precise sizes of 
which can be used to give an estimate of the site of the mutation. There are two features of FAP 
and the APC gene that make PTT a particularly attractive method. First, most FAP mutations 
(>95%) result in stop codons, which lead to premature termination of the APC protein. Second, 
the large size ofexon 15, where a high proportion of mutations occurs, means that gDNA can be 
used as the PCR template, rather than cDNA. The disadvantages ofPTT are that itjust can not be 
used to detect nonsense mutations, and it is an experimentally difficult method. 
Linkage analysis of theAPCgene 
The discovery of (CA)n dinucleotide repeats or microsatellites (Litt et al.，1989; Tautz et al., 
1989 and Weber et al., 1989) has provided over a thousand new and highly informative genetic 
markers for human genetic linkage studies. The C A repeat sequences, a kind of variable number 
of tandem repeat marker O^akamura Y et al., 1987), are dispersed on the human genome with 
50，000 to 100,000 copies. In the flanking region of the APC gene (30-70 kb downstream), there 
is a tandem repeat C A sequence which shows a length polymorphism with high frequency 
(Spirio L et al., 1991). In each case the method can be typed conveniently by PCR. Primers are 
designed from sequences known to flank the repeat regions, permitting PCR amplification of 
alleles whose sizes differ by integral repeat units. The PCR products can then be size-
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fractionated by polyacrylamide gel electrophoresis. A disadvantage of the method is that each 
allele consists of not just one fragment, but a series of fragments. These "shadow bands" 
sometimes obscure the position of allelic fragments, which makes genotyping difficult or 
impossible. This is especially vexing when typing individuals heterozygous for alleles differing 
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Figure 1-1. A large number of polyps present in the colon in Familial Adenomatous 
polyposis. 
41 
y ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ v ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 
Figure 1-2. "Bear tracks" CHRPE are the typical lesions in cases unassociated with FAP. Flat 
lesions with large hyperpigmentations are seen on clinical examination. 
4 2 
• 
Figure 1-3. The picture shows CHRPE lesions in a FAP patient. An oval pigment lesion with 





















































































































Chapter 2 Study Objectives 
1. To identify sequence aberrations in the APC gene in Chinese FAP patients and their family 
members. 
2. To evaluate the presymptomatic diagnostic value of CHRPE in FAP. 
3. To investigate the relationship between the APC gene mutations and CHRPE. 
4. To study the haplotype associated with FAP and examine its capability for providing 
accurate diagnostic information and presymptomatic diagnosis ofFAP. 
5. To formulate the basis for the establishment of an "FAP registry" for Hong Kong. 
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Chapter 3 Methodology 
3.1 Subjects 
All study subjects were recruited from patients attending the Eye Clinic, Prince of Wales 
Hospital, Hong Kong. After the diagnosis of FAP was established, their first-degree and second-
degree relatives were at risk ofFAP were recruited for study. 
3.2 CHRPE analysis 
3.2.1 Ophthalmoscopic Examination 
All subjects received pupillary dilation and fundal examination by a single observer with indirect 
ophthalmoscopy and biomicroscopy. The number, size and location of CHRPE were noted by 
drawing on retinal maps. Clinical data were collected through patient interviews and hospital 
records. 
3.2.2 Diagnostic criteria of CHRPE 
CHRPE lesions were classified into 5 types according to the criteria described by Berk et al 
(1988)，and by size into 3 grades. The location oflesions was divided into 3 sites: posterior pole, 
equatorial and peripheral (Table 1-1). Since small number of CHRPE may occur in normal 
subjects, the threshold for CHRPE positive is three or more lesions in one or both eyes. 
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3.3 Materials and Equipments 
3.3.1 Enzymes 
Taq D N A polymerase was obtained from GIBCO-BRL (Life Technologies, Gaithersburg, MD, 
USA). The restriction enzyme Hsp92II (lOU/ uL) accompanied with 10x buffer and bovine 
serum albumin (BSA) was purchased from Promega (Promega Corp., Madison, WI, USA). 
3.3.2 DNA Markers 
HaeIII digested pBR322 D N A marker was obtained from Sigma Chemical Company (St. Louis, 
MO, USA), lkb ladder D N A marker was obtained from GIBCO BRL. 
3.3.3 Reagent Kits 
The QIAamp Blood Kit for D N A extraction was purchased from QIAGEN (Qiagen, USA). 
MicrospinTmS-300 H R Columns for D N A purification were obtained from Pharmacia Biotech 
(Det Norske Veitas, Demmark). Thermo Sequenase cycle sequencing kit was obtained from 
Amersham (Amersham International PLC, Buckinghamshire, UK). 
3.3.4 Primersfor PCR 
Twenty-two primer pairs for PCR were purchased from GIBCO BRL. Table 3-1 summarizes the 
sequences of these 22 primers. 
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3.3.5 Chemicals and Reagents 
Acrylamide:bis-acrylamide (49:1，37:1 and 19:1) 40% solution, agarose, ammonium persulfate 
(AMBS), boric acid, ethidium bromide, ethylenediamine-tetraacetate di-sodium salt (EDTA), 
formamide, glycerol, sodium dodecyl sulfate (SDS), sucrose, Tris (hydroxymethyl) 
aminomethane hydrochloride (Tris), Triton X-100, xylene cyanol FF and urea were obtained 
from Sigma (St. Louis, M O , USA). Ammonium acetate, bromophenol blue, ethanol (absolute), 
hydrochloric acid, magnesium chloride and mineral oil were from E. Merck (Darmstadt, 
Germany). The dATP, dCTP, dGTP, dTTP and magnesium chloride for PCR and N,N,N',N'-
tetramethyl ethylenediamine (TEMED) were purchased from GIBCO BRL. Ficoll (type 400) 
was obtained from Pharmacia (Det Norske Veitas, Demmark). The Kodak XK-1 X-ray film and 
film developer and fixer were obtained from Eastman Kodak Company (Rochester, NY, USA). 
3.3.6 Radioisotopes 
a-32p-dCTP (6000 U/mmol, 10 mCi/mL) and y''P-ATP (>5000 Ci/mmol, 10 mCi/mL) were 
obtained from Amersham (Amersham International PLC, Buckinghamshire, UK). 
3.3.7 Solutions and Buffers 
-Agarose gel loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF and 15% type 
400 ficoll) 
-Ethanol (70%v/v) 
-Ethidium bromide (0.25 ug/mL) 
-Nuclei lysis buffer (10 mmol/L Tris pH 8.2，400 mol/L sodium chloride and 2 mmoVL EDTA) 
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-Polyacrylamide gel loading buffer (80% foraiamide, 0.1% bromophenol blue and 0.1% xylene 
cyanol FF) 
-Proteinase K (10 mg/mL，in 1% SDS and 2 mmol/L EDTA) 
-Saturated sodium chloride (approx. 6 mol/L) 
-Sodium dodecyl sulfate (SDS, 10% w/v) 
-lOx TAE buffer (10 mmol/L Tris and 1 mmol/L EDTA, pH7.5) 
-5x TBE buffer (45 mmol/L Tris-borate, 1 mmol/L EDTA, pH8.3) 
3.3.8 Equipment 
-Sorvall RC28S centrifuge was obtained from DuPont 0Slewtown, CT, USA) 
-G24 Environmental Incubator Shaker was bought from New Brunswick Scientific Co. (Edison, 
NJ, USA) 
-Response Spectrophotometer was purchased from Gilford, Japan 
-Perkin Elmer Cetus Thermal Cycler 480 was purchased from Perkin Elmer Co.OSforwalk, USA) 
-Electrophoresis Tank, model Horizon 11.14 was bought from GIBCO BRL (Life Technologies, 
Gaithersburg, M D , USA) 
-Electrophoresis Power Supply EPS 500/400 was obained from Pharmacia (Det Norske Veitas, 
Demmark) 
-UV-Transilluminator at 309 nm was purchased from UVP Inc. (CA, USA) 
-Movie Camera HS-CX7 was bought from Mitsubishi Electric Corp (Japan) 
•Kodak Wratten 23A gelatin filter was obtained from Sigma (St. Louis, MO, USA) 
-Vertical Electrophoresis Tank, model 2 was purchased from GIBCO BRL (Life Technologies, 
Gaithersburg, M D , USA) 
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-DC Power supply PS 3000 was bought from Hoefer 
-Model 583 Gel Dryer was obtained from BIO-RAD 
3.4 Methods 
3.4.1 Blood Collection 
Blood samples were collected by venipuncture into EDTA tubes from all study subjects. The 
blood samples were stored at -20 °C for not more than one month prior to D N A extraction. 
3.4.2 DNA Extraction 
The Salting-out Method 
D N A in a blood sample was extracted according to the salting-out method (Miller et al, 1988). A 
sample of2.5 mL EDTA blood was transferred to a 15 mL Elkay polypropylene test tube which 
was then filled with lOmL of freshly prepared sucrose lysis buffer. The sucrose lysis buffer must 
be kept on ice to lyse the blood cells. The nuclei were sedimented by centrifugation using a 
Sorvall RC28S centrifuge at 10,000 rpm at 4 °C for 12 minutes. The supernatant was discarded 
and the pellet washed twice with 10 mL of sucrose lysis buffer followed by centrifugation as 
above. The pellet was then resuspended in 1.5mL of nuclear lysis buffer followed by addition of 
100 |il 10% SDS and 50 ^ iL proteinase K. The nuclear lysate was digested ovemight at 37°C in 
an incubator with constant shaking (G24 Environmental Incubator Shaker). 200 ^ iL of saturated 
sodium chloride solution was added, and the tube was shaken vigorously for 15 seconds, 
followed by centrifugation at 10,000 rpm for 12 minutes. The supernatant containing the D N A 
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was transferred to another 15mL polypropylene tube, and 10 m L of absolute ethanol was added. 
The D N A was precipitated out by inverting the tube, and then was transferred to a 1.5mL 
polypropylene tube and washed using 70% ethanol. After drying the D N A under vacuum for 5 
minutes, 50 ^ L of distilled water was added. The D N A was dissolved ovemight at 37°C. The 
D N A sample was then stored at 4 °C. 
Method with QIAamp BloodKit 
D N A was extracted from whole blood using the QIAamp Blood Kit (QIAGEN, USA). The 
procedures were followed according to the protocol in the QIAamp Blood Kit Handbook. 
3.4.3 DNA Quantitation 
The D N A sample was diluted 20 times (lO^ iL DNA+190^L ^0)，and the absorbance at 260 nm 
and 280 nm was measured with the Response spectrophotometer. The reading at 260 nm allows 
calculation of the concentration of nucleic acid in the sample. An O D of 1 corresponds to 
approximately 50ug/ml for double-stranded DNA. The ratio between the readings at 260nm to 
280rnn provides an estimate of the purity of the nucleic acid. Pure preparations of D N A have 
OD260/OD280values ofl.8 and 2.0. 
3.4.4 Polymerase Chain Reaction (PCR) 
Twenty-two different segments (from exon 6 to 15) of the APC gene were amplified by 
polymerase chain reaction (PCR) using twenty-two primer pairs. Exon 15 was amplified with six 
PCRs because of its large size. Table 3-1 lists the primers and the sizes ofPCR products ofthe 
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APC gene used in this study. Each PCR tube contained 3.6 ng genomic DNA, 0.2 m M ofeach 
deoxy-nucleotide (dNTP), 0.5 U Taq D N A polymerase, 0.3 ^ g of each primer, lx PCR buffer 
from the manufacturer (GIBCO BRL) and 1.5-2.0 m M magnesium chloride (varies for different 
primers) in a final volume of 25 ^ iL. The reaction mixture was topped with 50 ^ iL ofmineral oil 
to prevent evaporation during PCR. The PCR was carried out on a thermal cycler. The 
programme began with a denaturation at 94°C for 5 minutes, followed by 35 cycles of 
denaturation at 94。C for 30 seconds, annealing at 54。C-64。C (depended on different primers) for 
1 minute and elongation at 72°C for 7 minutes. Ifthe PCR products were for SSCP analysis, 0.1 
pL of ot32p-dCTP was added to each reaction mixture prior to the PCR process. PCR 
optimization ofeach primer was accomplished by adjusting both the magnesium concentration in 
the PCR reaction mixture and the annealing temperature in the PCR temperature program. 
3.4.5 Agarose Gel Electrophoresis 
Horizontal agarose gel electrophoresis was carried out in a gel electrophoresis tank. An agarose 
gel of 2% was prepared by mixing 1.2g agarose and 60mL lx TAE buffer, and heating in a 
microwave oven until the agarose dissolved, then ethidium bromide was added to a final 
concentration of 0.5^ ig/mL. Then the solution was poured into an electrophoresis tray for 
solidification. Comb was placed immediately, the teeth ofwhich would form the sample wells. 
After the gel was completely set (30-45 minutes at room temperature), the comb was removed 
carefully. The solidified gel was placed in a tank of lx TAE buffer. D N A marker and samples 
mixed with loading buffer were loaded into the wells ofthe gel. Electrophoresis was then carried 
out at 80-100 m A until the bromophenol blue migrated the desired distance. The gel was then 
viewed under an ultra-violet G^V) transilluminator at 309 nm and a photograph taken with a 
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video camera (Movie Camera HS-CX7) using a Kodak Wratten 23A gelatin filter (Sigma) and 
video copy processor (p66E Video Copy Processor and K65HM Thermal Paper). 
3.4.6 Single Strand Conformation Polymorphism 
Polyacrylamide gels (acrylamide:bisacrylamide=49:l) with 5% glycerol and polyacrylamide gels 
(acrylamide: bisacrylamide=37:l) with 10% glycerol were prepared using a sequencing 
apparatus (GIBCO BRL). Compositions of the two different polyacrylamide gels are listed in 
Table 3-2. 25 ^ L of the ^ P^-labelled PCR product was mixed with 100 \iL of loading dye (95% 
formamide, 10 mmol/L EDTA, 0.1% bromophenol blue and 0.1% xylene cyanol), denatured at 
950c for 5 minutes and placed immediately on ice. 4 |iL ofthe reaction mixture was loaded on 
the gel and run in 0.5x TBE buffer in two conditions to increase sensitivity. The single strand 
conformation polymorphism (SSCP) conditions are listed in Table 3-3. After electrophoresis, the 
gel was then transferred to a 3 M M paper and dried on a gel dryer (Bio-Rad Laboratories). The 
dried gel was exposed to a Kodak XK-1 X-ray film (Eastman Kodak Co.) at -70。C overnight, 
and then the film was developed. 
3.4.7 Direct DNA Sequencing 
E)irect D N A sequencing were performed on the study samples showing mobility shift on SSCP 
using the Thermo Sequenase cycle sequencing kit from Amersham. 
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Amplification and purification of DNA samples 
D N A was amplified using the same primers and same conditions as those for PCR-SSCP 
analysis. The amplified D N A samples were purified with the use of a Microspin^^S-300 H R 
Column from Pharmacia Biotech. 
Labeling primers 
The primers in the sequencing reactions were labelled at the 3'-end with y^^P-dATP (Amersham). 
0.2 ^ g ofthe primer was mixed with 1 |iL of 10x Kinase reaction buffer, 1 |iL ofy^^P-dATP, 1 U 
T4 polynucleotide kinase and 4.8 ^ L distilled water in a final volume of 10 |iL. The mixture was 
incubated at 37°C for 30 minutes, and then heated at 95。C for 5 minutes to inactivate the kinase. 
Cycle sequencing 
For the sequencing reaction, 4 tubes labeled A, C，G and T were prepared. The A, C, G and T 
tubes were added 4 ^ L of the ddATP, ddCTP, ddGTP and ddTTP termination mix, respectively. 
A master mix was prepared by mixing 2 i^L reaction buffer, 1 ^ iL ^ 'P-labeled primer, 2 ^L 
Thermo sequenase DNA polymerase, 20 ng purified DNA template (3 ^ L) and 9.5 ^ L distilled 
water in a final volume of 17.5 ^iL, from which 4 ^ L was added to each ofthe 4 tubes. The total 
volume in each reaction was 8 ^iL. Each sequencing reaction tube was overlaid with one drop of 
mineral oil and placed in the thermal cycler. The cycling program was carried out using the same 
temperature program as for PCR. 4 ^ L of stop solution was added into each sequencing tube. 
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Denaturing Polyacrylamide Gel Electrophoresis 
The polyacrylamide gel solutions were prepared by mixing 25.2g urea, 3 m L 20x Glycerol 
Tolerant buffer and 9 m L 40% acrylamide solution (acrylamide: bisacrylamide=19:l), adjusting 
the final volume to 60 m L with deionized water and filtering through Whatman #1 paper. Then 
450 ^L 10% ammonium persulfate plus (AMPS) and 30 |iL tetramethylethylene diamine 
(TEMED) were added, and the gel was poured and allowed to set. The polyacrylamide gel was 
prepared in lx Glycerol Tolerant buffer using a sequencing apparatus (GIBCO BRL). The gel 
was pre-run at 70 W for half an hour, which should bring the temperature at the surface of the 
front glass plate to >40°C, as measured with a surface thermometer. The sequencing reaction 
products were denatured at 95。C for 5 minutes, 4 ^ L ofthe products was loaded on to the gel, 
and the gel was run at 60 W for 1.5 to 4.5 hours depending on the fragment size. After 
electrophoresis, the gels were then transferred to a 3 M M paper and dried on a gel dryer (Bio-Rad 
Laboratories). The dried gel was exposed to a Kodak XK-1 X-ray film (Eastman Kodak Co.) at -
W C ovemight, and then the film was developed. 
3.4.8 Microsatellite marker 
Indirect genotype analysis was performed in 4 ofthe 6 FAP families by using the microsatellite 
markers D5S1470，D5S2500, D5S1725, D5S1462 and D5S2501. The remaining 2 families 
(Family A and Family B) were not analyzed by this method, because Family A had few family 
members (only 3), and Family B that carried an APC mutation had clear segregation. 
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Labeling primers 
The forward primers were end-labeled with y^^P-dATP. 40 pmol of forward primer was mixed 
with 2 |iL of 10x Kinase reaction buffer, 5 ^ L ofy^^P-dATP, 2 U T4 polynucleotide kinase and 7 
|^ L distilled water in a final volume of20 |xL. The mixture was incubated at 37°C for 30 minutes, 
and then heated at 95°C for 5 minutes to inactivate the kinase. 
Polymerase Chain Reaction (PCR) 
A master mix was prepared by mixing 0.3 m M of each deoxy-nucleotide (dNTP), 2.0 U Taq 
D N A polymerase, 20 pmol labeled forward primer, 40 pmol unlabelled reverse primer, 32 ^ 1 of 
10 X PCR buffer, 2.0 m M magnesium chloride, 15 ^ il of 6% dimethylsulfoxide (DMSO), and 
172.7 ^il deionized water in a final volume of 256 ^ il. 4 |il of the master mix was added to each 
PCR tube with 12 ng D N A in a final volume of 5 ^ 1. Each PCR reaction tube was overlaid with 
one drop ofmineral oil. Samples were processed through an initial denaturation step at 94°C for 
five minutes, followed by 35 cycles of denaturation at 94。C for 30 seconds, annealing at different 
temperatures (D5S1470: 58。C，D5S2500: 58。C，D5S1725: 58。C，D5S1462: 60。C and D5S2501: 
57°C) for 1 minute and elongation at 72°C for 7 minutes. When the reaction program was 
finished，25 ^ iL ofloading dye (95% formamide, 10 mmol/L EDTA, 0.1% bromophenol blue and 
0.1% xylene cyanol) was added into each reaction tube. 
J^enaturing Polyacrylamide Gel Electrophoresis 
Electrophoresis was performed through a vertical 8% denaturing (8 mol/L urea) polyacrylamide 
gel (described in Direct D N A Sequencing Section) in lx Glycerol Tolerant Buffer at 60 W for 
3.5 hours. After electrophoresis, the gel was collected, dried, and exposed to a Kodak XK-1 X-




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 4 Results 
4.1 Study Subjects 
4.1.1 FAP index patients 
All the FAP patients (mean age 41.2) including 4 males and 6 females were previously 
diagnosed (mean age 32.9) and had undergone prophylactic colectomy. Extracolonic 
manifestations (ECM) including desmoids tumours, osteomas, epidermoid cysts and other 
malignant tumours were not present in all of them. Ophthalmoscopy was performed in 9 ofthe 
10 FAP patients. The remaining one did not have ophthalmoscopic examination because of 
terminal ill in FAP was at the time ofour study. 
4.1.2 Family members 
Six unrelated independent FAP families were studied, five ofthem from Guangdong province in 
southem China and the remaining one from Shanghai in middle China. Family members of 3 
generations were available for study in 2 families while only 2 generations were available in 4 
families. At least one FAP affected patient was included in each family. Thirty-three family 
members (mean age 26.4) including 13 males and 20 females from the 6 families were recruited 
for our study. Sixteen of them consented for sigmoidoscopy and no polyps in the colon were 
found in all of them. The remaining 17 family members did not consent to endoscopy. 
Extracolonic manifestations other than CHRPE were not found in any ofthem. Twenty-nine of 
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the 33 family members were examined by ophthalmoscopy, but the remaining 4 members did not 
consent for fundus examination. Genetic study was performed in all these 33 family members. 
4.1.3 Control subjects with CHRPE (unassociated with FAP) 
CHRPE were observed in 4 study subjects (age range 26-48, 2 male and 2 female) who attended 
our Eye Clinic for routine ophthalmologic examination. They had no other colonic or 
extracolonic features ofFAP. They also did not have a family history ofFAP. 
4.1.4 Normal control subjects 
Eight spouses (3 males and 5 females) of the affected individuals in the three FAP families were 
used as normal controls. They were healthy and had no family history ofhereditary disease. 
All the study subjects are summarized in Table 4-1. 
4.2 CHRPE Analysis 
4.2.1 CHRPE in FAP index patients 
The 9 FAP affected patients had one or more CHRPE lesions (100%). Seven ofthe 9 had more 
than three lesions in both eyes (77.8%) and the other 2 patients had only one or two "spot" 
lesions in the retinae, so the 2 patients were considered negative for CHRPE. Table 4-2 
summaries the characteristics of the CHRPE lesions in the 9 FAP patients. Totally 64 CHRPE 
lesions were observed in the 9 FAP index patients including 19 type A (29.7%), 26 type B 
(40.6%), 1 type C (1.60%) and 18 type E (28.1%) lesions. Type D lesions were not found. The 
distribution of these CHRPE lesions was <0.5 disk diameter (DD) in 49 of the 64 lesions 
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(76.56%), 0.5-1.0 D D in 11 lesions (17.19%) and >1.0 D D in 4 lesions (6.25%). Lesions of<0.5 
D D were the commonest size in FAP affected patients. The locations ofthe CHRPE lesions were 
evenly distributed in all three regions ofthe retina, with 23 (35.94%) in the posterior pole, 22 
(34.38%) in the equatorial and 19 (29.68%) in the peripheral. 
4.2.2 CHRPE in family members 
Out of the 29 relatives, 8 had one or more CHRPE lesions (27.6%) and 2 had more than three 
(6.9%) (Table 4-3). There were totally 20 CHRPE lesions found in these individuals including 3 
type A (15%), 3 type B (15%) and 14 type E (70%). Types C and D lesions were not found. 
Type E was the most common. Eighteen lesions were < 0.5 D D in size (90%), and 2 lesions were 
between 0.5-1.0 DD. Of the 19 CHRPE lesions, 7 (35%) were in the posterior pole, 7 (35%) 
were in the equatorial and 6 (30%) were in the peripheral. 
4.2.3 CHRPE in control subjects 
CHRPE was observed in the 4 controls with CHRPE during routine ophthalmoscopy. The 
subjects showed normal vision and visual field. But the CHRPE lesions were different from the 
CHRPE in FAP; they were solitary (one lesion per subject), big (about 5DD), round and 
hyperpigmented. 
CHRPE was not found in any of the 8 normal control subjects. 
4.2.4 Statistical analysis 
The ophthalmoscopic data (Table 4-4) were analyzed by the Chi-square test. Confidence limits 
Were calculated to estimate the possible range for sensitivity, specificity and predictive values. 
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The difference in CHRPE positivity between subjects negative and positive for polyps was 
significant 0)<0.001). The cumulative sensitivity ofCHRPE was 77.8% (95% confidence limits, 
43.88-100%; p<0.05) and the specificity was 94.6% (95% confidence limits, 86.95-100%; 
p<0.05). The positive and negative predictive values were 77.8% (95% confidence limits, 43.88-
100%; p<0.05) and 94.6% (95% confidence limits, 86.95-100%; p<0.05) respectively. The 
distribution of the CHRPE scores in FAP index patients and family members is shown in Figure 
4-1. 
4.3 PCR optimization 
Twenty-two PCR protocols have been established for screening and identification of APC 
mutations from exon 6 to 15 in all 55 studied subjects (Table 4-5). The PCR protocols were 
optimized for magnesium concentration in the PCR buffer and annealing temperature in the PCR 
cycle program. Figure 4-2 shows a sample of the PCR optimization. 
4.4 Single strand conformation polymorphism (SSCP) 
SSCP protocols were established for screening sequence alterations from wild type in all these 
PCR products. Eleven of the 22 PCR-SSCP analyses in the APC gene revealed different SSCP 
patterns; 8 were detected both at room temperature and 4°C, and 3 were observed only at 4°C 
(Table 4-6). SSCP alternate patterns were not detected in exons 7，12 and 14 with the conditions 
so far used. 
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4.5 Direct DNA sequencing analysis 
The SSCP positive conformers were further investigated by direct sequencing of the PCR 
products. The protocol for direct D N A sequencing analysis ofthe APC gene was established as 
described in the methods section. Four nonsense mutations (one of them novel) (Table 4-7), 3 
new silent mutations and 4 polymorphisms (Table 4-8) were identified. 
4.5.1 Nonsense mutations 
3068insA. 
The novel mutation is at nucleotide position 3068 in exon 15 ofthe APC gene. It is an one base 
pair (A) insertion at codon 1023 (Figure 4-4)，designated as 3068insA. The mutation creates a 
downstream stop codon within 17 nucleotides. This mutation was revealed on SSCP with one 
extra single strand band with slightly slower mobility from the PCR product ofexon 15D (Figure 
4-3). This mutation was detected in one FAP index patient (III1) in family A. 
Arg216Stop, 
The noted mutation is in exon 6 of the APC gene. It is a C—T substitution at nucleotide 646， 
changing codon 216 from arginine (CGA) to a stop codon (TGA) (Figure 4-6), designated as 
Arg216Stop or R216X. The mutation was revealed on SSCP with one extra single strand band 
with slightly slower mobility from the PCR product of exon 6 (Figure 4-5). The mutation was 
found in one FAP patient (III) in family D. 
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Arg283Stop 
The noted mutation is in exon 8. It is a C ^ T substitution at nucleotide 847 changing codon 283 
from arginine (CGA) to a stop codon (TGA) (Figure 4-8)，designated as Arg283Stop or R283X. 
It is expected to lead to a truncated and inactive protein. The mutation was revealed on SSCP 
with one extra single strand band with slightly faster mobility from the PCR product of exon 8 
(Figure 4-7). The mutation was detected in 5 subjects in family B，including 4 FAP patients (III， 
115，117 and III1) and 1 family member (III2). 
3183del5 
The noted mutation is in exon 15. This is a 5 base pair deletion ofACAAA at nucleotide 3183 in 
codon 1061 (Figure 4-10)，designated as 3183del5. This mutation produced a frameshift and 
created a stop codon (AAG) within 2 nucleotides. From the PCR product ofexon 15E, the 5 base 
pair deletion was revealed on SSCP with one extra single strand band with faster mobility and 
one single strand band migrated faster, and also a heteroduplex double strand band (Figure 4-9). 
The mutation was detected in one FAP affected patient (II8) in family C. 
Figure 4-11 is a summary of these 4 nonsense mutations ofthe APC gene detected. 
4.5.2 Novel silent mutations 
Serl050Ser in exon 9 
•» 
The novel silent mutation was found in exon 9 of the APC gene. It is a T~>G change at 
nucleotide position 1050，the third base of codon 350 (Figure 4-13). The amino acid is unaltered, 
since both TCT and TCG encode serine. This silent mutation was revealed by SSCP with one 
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extra single strand band with slower mobility from the PCR product ofexon 9 (Figure 4-12). The 
silent mutation was detected in 2 subjects in family E, one family member (III5) and one normal 
control (II8). 
G~M Transition in exon 10 and intron 10 boundary 
This novel silent mutation was found in intron 10. It is a G ^ A intronic change 5 bp downstream 
ofthe splice donor site for exon 10 (Figure 4-15). This silent mutation was revealed by SSCP 
with one extra single strand band of faster mobility from the PCR product ofexon 10 (Figure 4-
14). The silent mutation was detected in 6 subjects including one FAP patient and 5 family 
members in family C. 
Thr4965Thrinexon 15 
This novel silent mutation was found in exon 15J in a normal control (II3) in family A. It is an 
A~»G change at nucleotide position 4965, which is the third base of codon 1655 (Figure 4-17). 
The amino acid is unaltered, since both A C A and A C G encode threonine. This silent mutation 
was revealed on SSCP with one extra single strand band with faster mobility from the PCR 
product ofexon 15J (Figure 4-16). 
4.5.3 polymorphisms 
Exon 11 Polymorphism 
A polymorphism was detected in exon 11 of the APC gene. It is a change from C to T at 
nucleotide position 1458 (Figure 4-19)，which does not alter the amino acid (tyrosine). The 
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polymorphism was revealed by SSCP showing 3 different patterns (Figur 4-18), which signified 
homozygosity and heterozygosity for the polymorphism. Thirty-one of the 55 study subjects 
were observed to carry this polymorphism: 22 as heterozygotes, 9 as homozygotes. Frequencies 
of the rare allele (T) were: 0.35 in FAP patients, 0.29 in family members and 0.75 in normal 
controls. 
Exon 13 Polymorphism 
A polymorphism was found in exon 13. It is a change from A to G at nucleotide position 1635 
(Figure 4-21) that does not alter the amino acid threonine. Three different SSCP patterns were 
noted (Figure 4-20), which signified homozygosity and heterozygosity for the polymorphism. 
The polymorphism occurred in 8 study subjects including 1 FAP patients, 3 family members in 3 
different families and 4 normal controls. Frequences ofthe rare allele were 0.05 in FAP patients, 
0.045 in family members and 0.31 in normal controls in this study. 
Exon 15 Polymorphisms 
Two polymorphisms were found in exon 15 of the APC gene. They were changes from G to A at 
nucleotide position 4479 and from A to G at nucleotide position 5034 (Figure 4-23, Figure 4-25). 
Amino acids (serine and threonine) were not altered by these 2 polymorphisms. The 
polymorphisms were revealed from the 3 patterns detected by SSCP (Figure 4-22, Figure 4-24)， 
that indicated homozygosity and heterozygosity for the polymorphisms. These 2 polymorphisms 
occurred together in 8 study subjects including 1 FAP index patient, 3 family members in 3 
different families and 4 normal controls. They were the same subjects who possessed the exon 13 
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polymorphism. Frequences of the rare alleles were the same in the 2 polymorphisms, 0.05 in 
FAP index patients, 0.045 in family members and 0.31 in normal controls. 
4.6 Haplotype Analysis 
Haplotype analysis was carried out using 5 microsatellite markers in four FAP families. The 
order of these markers in the haplotypes is: D5S1470-D5S2500-D5S1725-APC-D5S1462-
D5S2501. These markers are tightly linked to the APC gene. Table 4-9 summarises the 
characteristics of these markers. These 5 microsatellite markers were informative because they 
revealed a large number of alleles (from 7 to 5) (Figure 4-26-29) and high PIC (polymorphism 
information content) values (from 0.567 to 0.838) in this study. 
4.7 Family studies 
4.7.1 Family A (Figure 4-30) 
The proband III1 ofthe family was a 29-years-old woman, she was affected with FAP and had a 
colectomy performed 8 years ago. She was heterozygous for the 3068insA mutation (novel 
mutation) (Figure 4-4) that leads to a truncated and inactive protein in the APC gene, and her 
®yes showed 15 CHRPE lesions in the retinae. Her mother 112 was the only family member 
examined, she did not carry the APC mutation and presented no CHRPE lesions in the retina. 
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Because the father ofthe proband could not join the study and the proband had no descendants, 
so it was difficut to continue to study FAP in this family. 
4.7.2 Family B (Figure 4-31) 
It is a typical FAP family in which FAP was observed in three generations. Proband (III) ofthe 
family was a 49-year-old woman who manifested polyposis coli and had a colectomy performed 
10 years ago. In the proband, seven small CHRPE lesions were observed in both eyes and a stop 
mutation (R283X) was detected in exon 8 (Figure 4-18). Her mother died of FAP several years 
ago. The R283X mutation was also detected in the proband's brother (115)，sister (II7) and 2 
children (1111，III2); among them 115，117 and III1 had been diagnosed clinically and the affected 
colons had been surgically removed. The CHRPE lesions were found in her 2 sisters (117，II9) 
and a child (III1). Since the subject (III2) inherited the APC mutation from her mother (III)，so 
she is at high risk and has been recommended to have endoscopy. The subject (II5) was a FAP 
patient and carried the APC mutation, but he only showed 2 CHRPE lesions in the retina. In 
addition，although subject (II9) had 5 CHRPE lesions in both eyes and didn't carry the mutation 
in the APC gene, it was recommended her colon be examined annually. 
4.7.3 Family C (Figure 4-32) 
The proband of the family, II8, was a 36-year-old woman with FAP who had undergone 
colectomy several years previously. Ophthalmologic examination revealed lesions characteristic 
ofCHRPE. Her eyes showed 16 small CHRPE lesions (< 1.0 DD) and 2 large lesions (>1.0 DD) 
in the retinae. In addition, a 5 base pair deletion was found at codon 1061 (3183del5) in exon 15 
6 9 
(Figure 4-10) in the proband. But no family members had any CHRPE lesions except III，the 
proband's brother, who showed 5 small CHRPE lesions in both eyes. However, III showed 
normal endoscopy and didn't carry the APC mutation. APC mutations were also not detected in 
all the family members. W e detected the novel silent mutation (IntronlOG/A) in 6 stubjects in 
this family including one FAP patient and 5 family members. In the haplotype analysis, the 
offsprings shared the alleles of the parents. W e were not able to determine which haplotype in 
the patient (II8) was associated with disease because 118 was the only FAP patient in this family 
and her mother (12) had died of unknown causes, so sporadic case also can not be eliminated. 
4.7.4 Family D (Figure 4-33) 
The proband ofthe family was a 64 year old woman (III)，on whom colectomy was performed 
several years ago. She was heterozygous for the R216X mutation (Figure 4-6) and showed 5 
CHRPE lesions in the both eyes. But the APC mutation and CHRPE lesions were not detected in 
all her 3 children. The haplotype that is associated with disease in this family can not be 
determined because the family size was small, consisting of only 3 members, and III was the 
only clinically defined patient in the family. The three offsprings inherited the same haplotype 
(4-2-3-5-2) from their mother, they showed normal endoscopy and didn't carry the APC 
mutation，so they are apparently at low risk. Because the parents of III had already died of 
unknown causes, the possibility cannot be eliminated that III was a sporadic case. 
7 0 
4.7.5 Family E (Figure 4-34) 
This family included three generations and 4 FAP patients, 2 of whom died several years ago. 
The proband 113 was a 55-year-old male FAP patient whose affected colon was removed 9 years 
ago. His mother and a sister died ofFAP in 13 and 9 years ago. His brother 119 was 28 year old 
and also was FAP affected, but unfortunately, he was terminally ill with FAP at the time ofour 
study. However, both mutations in the APC gene and CHRPE lesions in the retina were not 
detected in all the FAP patients and family members in this family. In the haplotype analysis, the 
haplotype (2-5-6-4) associated with disease had been determined in two FAP patients (II3 and 
II9). The offspring III1 inherited the haplotype associated with disease from her father, and was 
therefore at high risk. III1 should be recommended for endoscopy. 
4.7.6 Family F (Figure 4-35) 
The proband 112 of the family was a 43-year-old woman with FAP. The affected colon was 
removed 10 years ago. Her eyes showed 4 CHRPE lesions, but mutations in the APC gene were 
not detected in this study. In addition, CHRPE lesions and APC mutations were not found in any 
of the family members in this family. The haplotype associated with disease can not be 
determined becaues the family was too small and the proband was the only FAP patient in this 
family. However, the haplotype with disease maybe was 6-7-4-6, because the another haplotype 
(3-5-5-3) of the proband was also presented in her unaffected sister (II3). The proband's 
daughter (III1) inherited the suspicious haplotype with disease. The possibility that the proband 
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FAP index patient Family member 
Figure 4-1. Distribution of the CHRPE scores in FAP index patients and family 
members (来:FAP index patient, I： FAP family member) in this study. 
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1 2 3 4 5 6 
Figure 4-2. An example of amplification of a 481 base pair FAP D N A fragment ofthe PCR. 
Lane 1: pBR332 D N A marker; Lane 2: the control without DNA; Lane 3—6: different D N A 
samples. 
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1 2 3 4 5 6 
Figure 4-3. SSCP analysis in exon 15D (Table 4-5) ofthe APC gene. A mutant band (lane 5) 
presents the FAP patient (III1) in family A. Lane 1^4 and 6 show normal bands. The arrow 
indicates the position of the abnormal band. SSCP was performed with 6% polyacrylamide gel 
(acrylamide: bis-acrylamide = 37:1) containing 10% glycerol at 4。C. 
Novel 
Normal Mutation 
X G C ^ T G C A 
^ A ^ l | ^ / ” u 
ASP 令 \ _ « ^ 5 * i | _ ^ / 令 ASP 
*"^  2fy 
A mm 〜 � 〜 ft _ A 
Thr A^ • ^ 舞 』 一 S 
c • m ^ C c 
Pro C _ : _ 德 C 
A 广 _ _ « 麵 ~ \ A 
" • 丨 , 广 : ? 入 1 
Figure 4-4. Sequencing analysis of mutation in exon 15D of family A. One base pair (A) 
insertion is detected at nucleotide position 3068 in the FAP patient (AIII1). This is a novel 
mutation and creates a stop codon 17 nucleotides downstream. 
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H ^ ^ ^ H S H ^ ^ ^ ^ ^ B 
1 2 3 4 5 6 7 8 * . - . 
Figure 4-5. SSCP analysis in exon 6 of the APC gene. Mutant band (lane 2) presents the FAP 
patient (III) in family D. Lane 1，3">5 show the normal bands. The arrow indicates the location 
of the abnormal band. SSCP was performed with 6% polyacrylamide gel (acrylamide: bis-
acrylamide = 37:1) containing 10% glycerol at 4°C 
Normal mutation 
A C G T A C G T 
Arg ^ i . • ^ ？ /c/T* 
\ 5 f ^ y — j| / G G Arg-Stopcodon 
*'« 叠 \ _ J z " 3 _J \ *'« 
- i S ? S ^ \ [ , , 
G / ~ ~ 脚梦 _ 一 一 • \ G 
Ala 8 / •二： m^^ 一 ^ \ \ A.a 
A,g g / 翻 ： 一 • - \ S Arg 
.-:_ — ‘ 二 • 
. . - — 一 一 « » 
Figure 4-6. Sequencing analysis of the amplified exon 6 in the FAP patient (DII1). 
Heterozygosity for C G A ^ T G A is detected at codon 216 ofthe APC gene. This mutation results 
in a stop codon at the same position. 
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Figure 4-7. SSCP analysis in exon 8 of the APC gene. Mutant bands (lane 1, 2, 4，5 and 8) 
present in 4 FAP patients and one family member in family B. Lane 3，6. 7 and 9 show the 
normal bands. Lane N is a control without DNA. The arrow indicates location ofthe abnormal 
band. SSCP was performed with 6% polyacrylamide gel (acrylamide: bis-acrylamide = 49:1) 
containing 5% glycerol at room temperature. 
Mutation Normal 
A C G T A C G T 
^" K - v I • i J V s -
Thr C m • 寒 • A 
T 供 導 一 C Thr 
A • • • • • • 1 
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C/T* 9 着 • • • ^ 
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Figure 4-8. Sequencing analysis of exon 8 of Family B. Heterozygosity for C G A—TGA is 
detected at codon 283 of the APC gene in 4 FAP patients (BII1, BII5, BII7 and BIII1) and one 
family member (BIII2). This mutation results in a stop codon at the same position. 
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Figure 4-9. SSCP analysis in exon 15E (Table 4-5) of the APC gene. Mutant band (lane 1) 
presents in one FAP patient (CII8) in family C. Lanes 2^9 are normal samples. The arrow 
indicates the location of the abnormal band. SSCP was performed with 6% polyacrylamide gel 
(acrylamide: bis-acrylamide = 49:1) containing 5% glycerol at room temperature. 
Normal Mutation 
A C G T A C G T N l i ^ 
G,n J H ^ ^ ft^ J_^A de.et.on 
G / ^"^一一 S S ^ ^ \ 6^Stop codon 
� , " / ^ ^ t : V 
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Figure 4-10. Sequencing analysis of exon 15E in the FAP patient (CII8). A deletion of 5 base 
pairs is detected at codon 1061 of the APC gene. This mutation creates a stop codon in 2 
nucleotides downstream. 
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R216X R283X 3068insA3183del5 
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Exon 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
~ H f r 7 W / ^ / ^ A » 7 W * 7 W » 7 W / ^ A * 7 W / ^ A « = » ~ 
135 85 202 109 114 84 105 99 379 96 140 78 117 215 6577bp 
Figure 4-11. The four nonsense mutations of the APC gene detected in this study are showed 
above. 3068insA is a novel mutation. 
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Figure 4-12. SSCP analysis of exon 9 fragment of the APC gene. Mutant band (lane 9) 
appeared in one family member (EIII5) in family E. Lanes 1^8 and 10 show the normal bands. 
Lane N is the control without DNA. The arrow indicates the location of the abnormal band. 
SSCP was performed with 6% polyacrylamide gel (acrylamide: bis-acrylamide = 49:1) 
containing 5% glycerol at room temperature. 
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T G C A T G C A 
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Figure 4-13. Direct sequencing of exon 9 in the family member (EIII5). Heterozygosity for 
T C T ^ T C G (samesense mutation) is detected at codon 350 of the APC gene. This is a novel 
silent mutation. 
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Figure 4-14. SSCP analysis of exon 10 of the APC gene. Two patterns appeared in family C. The 
arrow indicates the pattern 1. Lane N is control without DNA. SSCP was performed with 6% 
polyacrylamide gel (acrylamide: bis-acrylamide = 49:1) containing 5% glycerol at room 
temperature. 
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Figure 4-15. Direct sequencing analysis of exon 10 for the 2 patterns. Heterozygosity for G—A 
is detected in intron 10 of the APC gene in the pattern 1. This is a novel silent mutation. 
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Figure 4-16. SSCP analysis of exon 15J (Table 4-5) ofthe APC gene. Mutant band (lane 8) 
presents in a normal control (II3) in family A. The arrow indicates the location ofthe abnormal 
band. Lane 1^7, 9^11 show the normal bands. SSCP was performed with 6% polyacrylamide 
gel (acrylamide: bis-acrylamide = 49:1) containing 5% glycerol at room temperature. 
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Figure 4-17. Direct sequencing analysis of exon 15J (Table 4-5) for the normal control. 
Heterozygosity for A C A ^ A C G (samesense mutation) is detected at codon 1655 ofthe APC 
gene. This is a novel silent mutation. 
Patterns 1 1 2 2 3 1 l i i 2 1 1 2 2 2 2 
90 
I _ ‘ _ 
••^w» mtmHmamrn^-' mi^ «—' «««» 
M M ^ i i H H I B M H H P K ^ I M m f e 
«•» ^P mmrntrnmrn 
1 2 3 4 5 6 7 8 9 10 11 12 13141516 
Figure 4-18. SSCP analysis of exon 11 of the APC gene. Three patterns were observed. Pattem 1: 
lane 1^2, 6—9，and 11—12. Pattem 2: 3^4, 10 and 13—16. Pattem 3: lane 5. SSCP was 
performed with 6% polyacrylamide gel (acrylamide: bis-acrylamide = 49:1) containing 5% 
glycerol at room temperature. 
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Figure 4-19. Direct sequencing analysis of exon 11 for the 3 SSCP patterns (Figure 4-18). 
Heterozygosity for T A C ^ T A T (samesense mutation) is detected in pattem 2 and homozygosity 
for T A C ^ T A T in pattem 3. Pattem 1 is the normal pattem. 
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Figure 4-20. SSCP analysis of exon 13 ofthe APC gene. Three patterns are noted. Pattern 1: lane 
1. Pattern 2: lane 6，7. Pattern 3: lane 2^5 and 8—14. SSCP was performed with 6% 
polyacrylamide gel (acrylamide: bis-acrylamide = 49:1) containing 5% glycerol at room 
temperature. 
Pattern 2 Pattern 3 Pattern 1 
T G C A T G G A T G C A 
側 ^ ^ ? ^ : > ^ ^ 1 ^ ‘ 
"e | E ^ - " ^ | ^ m J ' ^ lle 
G G ^ r ^ f c ^ ^ ^ ^ % ^ | _ a ^ ^ G 
Ala/Ala C C ^ ^ * _ ^ ^ ^ H ^ F ^ 一 。Ala " ' v - t f 1 ^ j r 
• ^ ^5 =5 =5 、 ” 
Heterozygous Normal Homozygous 
Figure 4-21. Direct sequencing analysis of exon 13 for the 3 patterns. Heterozygosity for 
GCA—GCG (samesense mutation) is detected in pattern 2 and homozygosity for G C A ^ G C G in 
pattem 1. Pattem 3 is the normal pattern. 
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Figure 4-22. SSCP analysis ofexon 15 MCR-C (Table 4-5) ofthe APC gene. Three patterns are 
observed. Pattern 1: lane 1^2, 4~>6 and 9~>10. Pattern 2: lane 3. Pattern 3: lane 7^8. SSCP 
was performed with 6% polyacrylamide gel (acrylamide: bis-acrylamide = 49:1) containing 5% 
glycerol at room temperature. 
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Figure 4-23. Direct sequencing analysis of exon 15 (MCR-C) (Table 4-5) for the 3 patterns. 
Heterozygosity for A C G ^ A C A (samesense mutation) is detected in pattem 3 and homozygosity 
for ACG">ACA in pattem 2. Pattem 1 is the normal pattem. 
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Figure 4-24. SSCP analysis of exon 15 K (Table 4-5) of the APC gene. Three patterns are noted. 
Pattem 1: lane 1-2，4-6 and 9. Pattem 2: lane 3. Pattem 3: lane 7-8. Lane N is the control without 
DNA. SSCP was performed with 6% polyacrylamide gel (acrylamide: bis-acrylamide = 49:1) 
containing 5% glycerol at room temperature. 
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Figure 4-25. Direct sequencing analysis in exon 15 K from the 3 patterns. Heterozygosity for 
TCG">TCT (samesense mutation) is detected in pattem 3 and homozygosity for T C G ^ T C T in 
pattem 2. Pattem 1 is the normal pattem. 
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Figure 4-26. Haplotype analysis using microsatellite marker (D5S2500) in family C. Types of 
alleles are showed with the arrows. All subjects are heterozygous in the alleles typed. 
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Figure 4-27. Haplotype analysis using mirosatellite marker (D5S1725) in family D. Different 
types are showed with the arrows. Lanes 2, 3，4 and 5 are heterozygous for the alleles, lane 1 is 
homozygous. 
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Figure 4-28. An example ofhaplotype analysis using mirosatellite marker (D5S1462) in family E. 
Types of alleles are showed with the arrows. Lanes 1，2, 4^8, 11，12 and 14 are heterozygous 
for the alleles detected by these D N A markers. Lanes 3，9, 10 and 13 are homozygous. 
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Figure 4-29. An example ofhaplotype analysis using mirosatellite marker (D5S1470) in family F. 
Different alleles are showed with the arrows. All subjects are heterozygous for these alleles 
detected by these D N A markers. 
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Figure 4-30. The pedigree of family A. Black symbol indicates affected patient with 
FAP, shadow indicates CHRPE and blank symbols represent unaffected or unknown 
status at the time of study. Y is the age of the subject was first recruited and examined. 
III is the first husband of 112，113 is the second husband of II2. 3068insA is a novel 
mutation and was detected in the FAP patient (III1) in this family. 4965A/G found in 
113 is a novel silent mutation. 
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Figure 4-31. The pedigree of family B. Black symbol indicates affected patient with FAP, shadow 
indicates CHRPE and blank symbols represent the unaffected or unknown status at the time of study. Y 
is the age of the subject was first recruited and examined. R283X mutation was detected in 4 FAP 
patients (III, II5,117 and III1) and one family member (III2) in this family. 
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Figure 4-32. Pedigree and haplotype analysis by five microsatellite markers in family C. Black symbol 
indicates the affected patient with FAP’ shadow indicates CHRPE and blank symbols represent unaffected or 
unknown status at the time of study. Y is the age of the subject was first recruited and examined for this 
study. 3183del5 mutation was detected in the FAP patient (II8). bitronlOG/A is a novel silent mutation and 
was found in 6 subjects (II’ III，113，115，116 and II8) in this family. The solid lines below each symbol 
indicate the two haplotypes obtained for each person. The types of the two alleles are shown for each marker. 
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Figure 4-33. Pedigree and haplotype analysis by five microsatellite markers in family D. Black symbol 
indicates affected patient with FAP, shadow indicates CHRPE and blank symbols are unaffected or 
have unknown status at the time of study. Y is the age of the subject was first recruited and examined 
for this study. R216X mutation was detected in the FAP patient (III). The solid lines below each 
symbol indicate the two haplotypes obtained for each person. The types of the two alleles are shown 
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Figure 4-34. Pedigree and haplotype analysis by four microsatellite markers in family E. Black symbols 
indicate affected patient with FAP and blank symbols are unaffected ofunknown status at the time of study. Y 
is the age of the subject was first recruited and examined for this study. 112 is the first wife of 113 and 114 is the 
second wife of II3. The novel silent mutation 1050T/G was detected in 2 subjects (H8 and III5) in this family. 
The solid lines below each symbol indicate the two haplotypes obtained for each person. The types of the two 
alleles are shown for each marker. The recombination sites are indicated by RS. The haplotype associated with 
the disease is 2-5-6-4, and is presented in the two affected FAP patients (IB and II9). The offspring III1 has 
inherited the haplotype associated with the disease from her father. 
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Figure 4-35. Pedigree and haplotype analysis by four microsatellite markers in family F. Black 
symbol indicate affected patient with FAP, shadow indicates CHRPE and blank symbols are 
unaffected or have unknown status at the time of study. Y is the age of the subject was first 
recruited and examined for this study. The solid lines below each symbol indicate the two 
haplotypes obtained for each person. The types of the two alleles are shown for each marker. The 
recombination sites are indicated by RS. The question mark indicates the haplotype which is likely 
to be associated with the disease. 
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Chapter 5 Discussion 
5.1 The predictive value of CHRPE in FAP patients and family members 
The incidence of CHRPE in FAP reported in different studies ranges from 66-97% (Berk et al., 
1988; Blair et al.，1980; Baker et al., 1988; Bum et al.，1991; Polkinghome et al., 1990; Romania 
et al., 1989; Chapman et al., 1989). In our study, the incidence of CHRPE in FAP was 77.8%. 
The explanation for these variations of incidence is not clear. It is possible that different 
ophthalmologists may vary in their criteria for recording retinal abnormalities, especially for 
small lesions, or that patient populations may also differ. In this study, the criteria of CHRPE 
positive was three or more lesions in one or both eyes, because small numbers of CHRPE may 
occur in normal subjects (Bum et al., 1991). This criteria is thought to be specific and sensitive 
for FAP (Lewis et al., 1984; Romania et al.，1989). However, ophthalmologists may not detect 
all lesions because Traboulsi et al. (1987) identified 70 lesions of CHRPE at autopsy in the 
retinae of a FAP patient with only 24 CHRPE lesions previously described with fundoscopy. In 
our study, 4 family members (the ages were 2-3 year old) did not consent for ophthamoscopy, 
but it was possible to detect CHRPE lesions in them. CHRPE is a congenital condition, it can be 
observed at any time after birth. Romania et al. (1989) urged that all family members at risk of 
inheriting FAP should be examined by ophthamoscopy at the earliest age possible. The 
sensitivity and specificity of CHRPE in FAP were 0.78 and 0.95 in this study. Those figures are 
close to the reports in the Caucasian and Japanese populations, 0.78 and 0.95 as reported by 
Traboulsi et al (1987)，or 0.862 and 0.997 as reported by Shozo et al (1990). The incidence of 
CHRPE in possible carriers is close to the calculated value ofthe expression ofthe polyposis. A 
• 
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retinal examination positive for the characteristic RPE lesions signifies a high risk for FAP, 
whereas a negative retinal examination is uninformative. Althuough CHRPE positive may not 
always indicate an FAP carrier status and negative may not eliminate an FAP carrier status, but 
ophthalmologic examination is a direct, noninvasive and inexpensive test, and CHRPE maintains 
its role in FAP screening, especially in families with known APC mutations. Our results are 
consistent with a previous study on 11 Chinese FAP patients who all had CHRPE lesions (Lam 
et al. 1998). CHRPE is a valuable early predictive marker of FAP, and in addition to mutation 
analysis and linkage study of the APC gene, the possibility for presymptomatic diagnosis ofFAP 
is almost 100 percent. Our results also indicate that establishment of a FAP registry in Hong 
Kong would be highly desirable in which occular screening and genetic counsel can be provided 
to FAP patients and their family members. 
5.2 The laboratory techniques in this study 
5.2.1 PCR optimization 
PCR is the basis for the preparation of a target D N A fragment for the detection ofbase changes 
in many different methods and it is widely use in genetic studies. However, a successful PCR 
portocol depends on stringent reaction conditions, so the procedure of PCR optimization is 
required. Magnesium concentration and annealing temperature were the major factors during 
PCR optimization in this study. Magnesium ion influences enzyme activity, increases melting 
temperature (Tm) of double strand D N A and forms soluble complexes with dNTP, which is 
essential for dNTP incorporation. Higher magnesium concentration could increase nonspecific 
PCR products that display nonspecific bands on the agrose gel. The magnesium concentration 
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may be varied from approximately between 0.5mM to 5 m M to obtain the optimum. The 
annealing temperature is the temperature at which the primer is able to bind to the target D N A 
but are unable to bind to D N A that does not match the target D N A exactly. The annealing 
temperature is one of the most important factors in PCR optimization. In many situations, 
exclusive amplification of the desired product is achieved after modifying the annealing 
temperature. The range of annealing temperature is between 50°C to 65°C (Philip et al. 1992). In 
our study, twenty-two PCR protocols have been established and they are summarized in Table 4-
5. In addition, in order to increase PCR specificity, contamination must be avoided. Some 
general rules for PCR set-up should be followed for preventing PCR contamination, such as: 
using personal reagent sets and pipets, wearing gloves and changing them frequently, and using 
disposable materials. For every PCR, negative water control should be needed to check PCR 
reagent for contaminations. 
5.2.2 Single strand conformation polymorphism (SSCP) 
Single strand conformation polymorphism (SSCP) is used widely for detecting both mutations 
and polymorphisms for heterzygous or homozygous. The sensitivity ofSSCP for detecting point 
mutations can be improved by changing a variety of SSCP conditions. Factors that affect the 
sensitivity of SSCP include the length of the PCR fragment, temperature ofthe running gel, the 
method ofPCR denaturation, composition of gel and electrophoretic conditions (Hayashi, 1991). 
The electrophoresis temperature is an important factor in detecting single strand comformation. 
At lower temperatures, electrophoretic mobility was retarded. The single strand D N A mobility 
was also dependent on temperature, so it was necessary to ensure that temperature gradients 
within the same gel were minimized by sufficient cooling for the heat generated. Gel 
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composition is the another important factor for effecting the sensitivity of SSCP. The extent of 
cross-linking is expressed by the ratio of N,N'-methylbisacrylamide to total acrylamide 
concentrations, the ratio affected both D N A as well as indicator dye migration (Dean et al. 1991). 
Glycerol content of the gel affected the relative mobilities ofsingle strand DNA, because oftheir 
denaturant properties on the secondary conformation of macromolecules (Orita et al. 1989). In 
this study, every SSCP was performed under two conditions to increase sensitivity: 6% 
acrylamide gel containing 5% glycerol with acrylamide:bisacrylamide ratio of 49:1 at room 
temperature and 6% acrylamide gel containing 10% glycerol with acrylamide: bisacrylamide 
ratio of 37:1 at 4。C. Eleven SSCP positive conformers were detected using this method, 8 of 
them were found in both conditions, 3 were just found in 10% glycerol at 4。C. The SSCP 
condition, 6% acrylamide gel containing 10% glycerol with acrylamide: bisacrylamide ratio of 
37:1 at 4。C，ensure high sensitivity. It identified that the conformation of single strand D N A 
which can change by different gel temperature used during electrophoresis (Hayashi, 1991). The 
reported sensitivity of detecting mutations with SSCP was about 70% (Hayashi, 1992). In this 
study, 2 conditions were used to increase the sensitivity ofSSCP over 90%. 
5.2.3 Direct DNA sequencing 
Direct D N A sequencing is taken to identify the base difference for the SSCP positive conformers. 
h this study, 4 nonsense mutations, 4 polymorphisms and 3 slient mutations were detected using 
direct D N A sequencing. It is an effective method for detecting all kinds of mutations and has 
been widely used in many laboratories. But the method is laborious and radioisotopes have to be 
used. Automated sequencing will overcome the disadvantage, but it needs time to set up the 
programe in routine practice. 
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5.3 Novel mutations in the APC gene 
The novel mutation 3068insA that creates a stop codon 17 nucleotides downstream is a one base 
pair (A) insertion at codon 1023 in exon 15 of the APC gene. W e found the mutation in a 29-
year-old woman (AIII1) in family A. She had been clinically diagnosed with FAP and 
prophylactic colectomy was performed on her. She is heterozygous for the mutation, and fifteen 
CHRPE lesions were observed in both eyes. It is difficult to study the mutation due to small 
family members in this family. However, it is necessary to analyze the novel mutation in a large 
number of Chinese FAP patients in future. 
5.4 Reported mutations in the APC gene 
5.4.1 3183del5. 
The mutation that is a 5 base pair deletion of A C A A A at codon 1061 is a hot spot in the APC 
gene and has been reported by several groups including Japanese and Caucasians. Michiko et al 
(1995) reviewed more than 100 germline mutations ofthe APC gene in 400 FAP families and 
found 3183del5 mutaion in 14 FAP families. This mutation produced a frameshift and created a 
stop codon (AAG) within 2 nucleotides. The mutation identifies the rule that deletions in the 
APC gene often occur at positions containing repeated sequences within the coding sequence, 
and cause frameshifts, which result in stop codons further downstream. W e detected the mutation 
in a 36-year-old woman with FAP who had undergone colectomy several years previously. She 
is heterozygous for the mutation, and 18 CHRPE lesions were found in both eyes. 
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5.4.2 R216X and R283X 
The mutation R216X was first reported in 2 of the 70 Japanese FAP patients (Miyaki et al. 1994)， 
and R283X mutation was detected in one of the 100 FAP patients in French (Olschwang et al. 
1993). The two mutations are C to T substitutions which change arginine (CGA) to a stop codon 
(TGA). APC germline mutations are more than 80% base substitutions from cytosine to other 
nucleotides. It can be explained by the theory that a large number of mutations from C and G 
occurs as a result of transient misalignment of the bases at the replication fork (Cooper et al. 
1990). It can also be explained by the fact that about 98% ofmutations in the APC gene result in 
stop codons TGA, T A G and TAA. R216X was detected in a 64-year-old woman (DII1) who was 
an FAP index patient and had colectomy. She was heterozygous for the mutation. R283X was 
found in 5 study subjects in the family B, including 4 FAP affected patients and 1 family 
member. They are all heterozygous for the mutation. 
5.5 Silent mutations and Polymorphisms in the APC gene 
5.5.1 Novel silent mutations 
Serl050Serinexon9 
The novel silent mutation found in exon 9 of the APC gene was a T ^ G base change at 
nucleotide position 1050，which does not alter the amino acid (serine). W e detected this silent 
mutation in a family member (EIII5) and a normal control (EII8). This silent mutation may not 
be linked to FAP or CHRPE (Table 4-3)，but it is necessary to screen for this silent mutation in a 
large number ofFAP affected patients and normal controls. 
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G—A Transition at exon 10 and intron 10 boundary 
The novel silent mutation is a transition 5bp downstream from the exon 10-intron 10 boundary. It 
is unlikely to be a splice site mutation because the probability ofa mutation in the (-6) position to 
give a 3’ splice site mutation is only 12% (Krawczak et al. 1992). The novel silent mutation was 
found in 6 study subjects including 1 FAP index patient and 5 family members in family C. It is 
also necessary to screen the silent mutation in a large number of FAP affected patients and 
normal controls for study the relationship between the silent mutation and FAP. 
Thr4965Thrinexon 15 
The novel silent mutation was an A~>G base change at nucleotide position 4965, that does not 
alter the amino acid (threonine). Because the silent mutation was just found in a normal control, 
it is necessary to screen more FAP index patients and normal controls to determine the features 
of this silent mutation. 
5.5.2 Polymorphisms 
1458C/Tin exon 11 
1458C/T is a common polymorphism in the APC gene. Nagase et al (1992) tested 150 
individuals and found frequency of the polymorphism was 0.43/0.57 (with or without an Rsal 
site). W e detected the polymorphism in 31 of 55 study subjects, 22 ofthe 31 were heterozygous 
and 9 were homozygous. Frequency of the rare allele (T) was 0.35 in FAP patients, 0.29 in 
family members and 0.75 in normal controls. The polymorphism is not specific to FAP patients, 
in agreement with the previous report by Nagase et al. in 1992. 
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1635A/Gy 4479G/A and 5043A/G in exon 13 and 15 
Frequencies of these 3 polymorphisms were reported to be 0.34/0.66 in 1635A/G, 0.35/0.65 in 
4479G/A and 0.64/0.36 in 5043A/G with or without cutting site (Miyoshi et al. 1992, Powell et 
al. 1992 and Nagase et al. 1992). These 3 polymorphisms are very common in the APC gene. In 
this study, it is interesting to find that the three polymorphisms occurred together in 8 study 
subjects, including 1 FAP index patients, 3 family members in 3 different families and 4 normal 
controls. Seven ofthe 8 study subjects were heterozygous and one was homozygous for the three 
polymorphisms. Frequencies of the rare alleles for the 3 polymorphisms were 0.05 in FAP 
affected patients, 0.045 in family members and 0.31 in normal controls. Frequencies ofthe 3 
polymorphisms in this study were different from other reports may be due to small individuals 
tested. However, we could not find relationships between the 3 polymorphisms and FAP or 
CHRPE (Table 4-3) that agree with the reports of other groups (Miyoshi et al. 1992，Nagase et al. 
1992 and Powell et al. 1992). 
5.6 The relationship between the APC gene mutation and CHRPE 
The correlation between location of mutations in the APC gene and CHRPE in FAP patients was 
reported (Olschwang et al. 1993，Wallis et al. 1994). Retinal lesions are almost absent ifthe 
mutation occurs before exon 9，but are consistantly present if occurs after this exon. However, 
our study showed different results. Table4-2 summaries FAP, CHRPE and APC mutations in all 
10 FAP patients in this study. The mutation R216X was detected in exon 6 ofthe APC gene in 
an FAP affected patient (DII1), and 5 CHRPE lesions were observed in her both eyes. The 
mutation R283X was found in exon 8 of the APC gene in 5 study subjects including 4 FAP 
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affected patients (BII1, BII5, BII7 and BIII1) and 1 family member (BIII2). CHRPE lesions were 
observed in 3 of the 5 study subjects. Our study indicated CHRPE lesions are present if the 
mutation occurs before exon 9 of the APC gene. Mutations 3068insA and 3183del5 were 
detected in exon 15 of the APC gene in 2 FAP index patients (AIII1 and CII8) respectively and 
both of them showed more than 15 CHRPE lesions in both eyes. CHRPE lesions perhaps are 
serious if the mutations occur at codons 1023 and 1061 ofthe APC gene. But further analysis of 
a large number of patients is required to determine whether the position of the APC gene 
mutation is correlated with CHRPE. W e detected APC mutations in only 7 of the 10 FAP 
patients (70%). One of the reasons may be SSCP analysis is not sensitive enough to detect all. 
mutations. Moreover, we finished screening the APC gene from exon 6 to 15 (codon 216-2843), 
but exon 1-5 were not tested. However, about 9% ofthe mutations occurred in exon 1-6 ofthe 
APC gene (Joyce et al. 1995). The author reviewed 174 germline mutations in the APC gene, 
only 16 mutations in exon 1 to 6. However, we detected one APC mutation R216X in exon 6 in 
the 10 FAP patients, it is necessary to screen exon 1-5 ofthe APC gene in Chinese FAP patients. 
5.7 Haplotype analysis 
Haplotype analysis is a rapid and efficient method for analyzing the genotype with hereditary 
disease and presymptomatic diagnosis of FAP. In this study, we attempted haplotype analysis 
using 5 different closely linked and polymorphic microsatellite markers flanking the APC gene 
in 35 individuals consisting of 4 FAP families. The haplotype associated with disease was 
detected in Family E (Figure 4-34). However, the alleles associated with disease could not be 
determined in the other 3 FAP families due to the small number offamily members studied. W e 
113 
should not ignore the rare possibility of recombination. A combined use of the polymorphisms 
near or just in the APC gene, and making a haplotype of the gene for analysis, will raise the 
informativity and reliability further. The recombinant events involved D5S1470 and D5S2500 
markers, therefore we were able to clarify that these two markers are farther away from the APC 
gene than D5S1725 and D5S1462. Genetic mapping gives only a crude estimate ofthe size of 
the critical region, beacause genetic distances between markers are usually known with much 
less certainty than the map order. Up to now, distances between the APC gene and these markers 
have not been reported and there is no publications about using these 5 microsatellite markers 
(D5S1470, D5S2500, D5S1725, D5S1462, D5S2501) to perform haplotype analysis in FAP 
families. In our study, these markers showed high heterozygosity with high allelic frequency 
(Table 4-9) and multiple bands (Figure 4-26 to 4-29). Whether new polymorphisms discovered 
in the Chinese FAP patients in this study are suitable for use as polymorphic markers for 
haplotype remain to be investigated. Although the use of haplotype segregation analysis is 
widespread for presymptomatic diagnosis, its informativeness is still limited in some cases, such 
as: key family members being unavailable, linkage markers not informative in the family, or a 
sporadic case with few family members. 
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Chapter 6 Conclusion 
1. CHRPE is an early clinical marker with high sensitivity, specificity and predictive value for 
FAP. Opthalmologic examination is a direct, noninvasive and inexpensive test in FAP 
screening. 
2. The novel and all 3 previously reported mutations found in this study are nonsense mutations 
and segregated with CHRPE. 
3. Our study indicated that the site of an APC gene mutation influences CHRPE expression but 
is not the only factor responsible for the presence and number of retinal lesions in FAP 
patients. 
4. Indirect genotyping of FAP with highly polymorphic microsatellite markers flanking the 
APC gene maybe is a rapid, efficient, and highly reliable method for presymptomatic 
diagnosis ofFAP. 
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